Jeffrey H. Lee, MD, MPH, FASGE, FACG, AGAF

Peer-Reviewed Articles

1. Nakshabandi AA, Ali FS, Albustami I, Hwang H, Qiao W, Johnston NC, Shaikh AS, Coronel E, Ge PS, Ross W, Weston B, Lee JH. Biliary drainage in hilar and perihilar cholangicarcinoma; 25-year experience at a tertiary cancer center. Gastrointest Endosc 99(6):938-949, 2024. e-Pub 2024.
2. Jain AJ, Lendoire M, Boyev A, Newhook TE, Tzeng CWD, Cao HST, Coronel E, Lee SS, Hu ZI, Javle M, Lee JH, Vauthey JN, Chun YS. Revisting malignant masquerade at the liver hilum. Ann Surg Oncol 31:3062-3068, 2024. e-Pub 2024.
3. Al Nakshabandi A, Ali FS, Albustami I, Hwang H, Qiao W, Johnston NC, Shaikh AS, Coronel E, Ge PS, Ross W, Weston B, Lee JH. Biliary Drainage in Hilar and Perihilar Cholangiocarcinoma; 25-Year Experience at a Tertiary Cancer Center. Gastrointest Endosc. e-Pub 2023. PMID: 38092128.
4. 259. Nakshabandi AA, Lee JH. Contemporary advances in the endoscopic management of cholangiocarcinoma: a review of accomplished milestones and prospective opportunities. Expert Rev Gastroenterol Hepatol 17(2):175-187, 2023. PMID: 36683580.
5. Vassilakopoulou M, Chen HC, Wang X, Harada K, Iwatsuki M, Das P, Blum Murphy M, Matamoros A. Jr, Sagebiel T, Devine C, Thomas I, Sanders EM, Shanbhag N, Rogers, Lee JH, Weston B, Bhutani MS, Hofstetter W, Nguyen Q, Badgwell BD, Ajani JA. Localized gastroesophageal adenocarcinoma in the elderly: is age a factor associated with suboptimal treatment?. Oncology 101(3):153-158, 2023. e-Pub 2022. PMID: 36412619.
6. Emelogu IK, Campbell DR, Lanke G, Yu AC, Nogueras-Gonzalez G, Lum P, Coronel E, Ge PS, Ross WA, Weston BR, Katz MH, Lee JH. A decade’s experience of managing suspected pancreatic adenocarcinoma at a tertiary cancer center. Ann Gastroenterol 36(1):81-86, 2023. PMID: 36593816.
7. Low DJ, Yu A, Liu C, Ali FS, Nakshabandi AA, Coronel E, Ge P, Lee JH. Endoscopic retrograde cholangiopancreatography in patients with pancreaticoduodenectomy with and without the use of a rigidizing overtube. Int J Gastrointest Interv 12:115-122, 2023.
8. Kumar S, Bahdi F, Emelogu IK, Yu AC, Coronel M, Ge PS, Coronel E, Ajani AJ, Weston B, Lynch P, Ross WA, Lee JH. How much progress have we made?: A 20-year experience regarding esophageal stents for the palliation of malignant dysphagia. Dis Esophagus, 2022. PMID: 34937091.
9. Kang Y, Deng E, Ling J, Li X, Chiang Y, Koay EJ, Wang H, Burks JK, Chiao PJ, Hurd MW, Bhutani MS, Lee JH, Weston BR, Maitra A, Ikoma N, Tzeng CWD, Lee JE, DePinho RA, Wolff, RA, Pant S, McAllister F, Katz MHG, Fleming JB , Kim MP. 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. J Clin Invest 1232(24), 2022. PMID: 36282600.
10. Low DJ, Hong Z, Lee JH. Artificial intelligence implementation in pancreaticobiliary endoscopy. Expert Rev Gastroenterol Hepatol 16((6)):493-498. e-Pub 2022. PMID: 35639864.
11. Lee JH, Yu AC, Ali FS, Ahmed O, Lynch P, Ge P, Coronel E, Kim M, Coronel M, Folloder J, Katz MHG. The conundrum in endoscopic management of duodenal polyps: a tertiary cancer center experience. Expert Rev Gastroenterol Hepatol 16(6):569-576, 2022. PMID: 35687675.
12. Coronel M, Lee JH, Coronel E. Endoscopic Ultrasound for the Diagnosis and Staging of Biliary Malignancy. Clin Liver Dis 26(1):115-125, 2022. PMID: 34802657.
13. Kumar S, Bahdi F, Emelogu IK,Yu AC, Coronel M, Ge PS, Coroenl E, Ajani AJ, Weston B, Lynch P, Ross WA, Lee JH. How much progress have we made?: A 20-year experience regarding esophageal stents for the palliation of malignant dysphagia. Dis Esophagus. e-Pub 2021. PMID: 34937091.
14. Gan Q, Roy-Chowdhuri S, Duose DY, Stewart J, Coronel E, Bhutani MS, Lee JH, Weston B, Ge PS, Ross WA, Maitra A. Adequacy evaluation and use of pancreatic adenocarcinoma specimens for next‐generation sequencing acquired by endoscopic ultrasound–guided FNA and FNB in Cancer Cytopathology. Cancer Cytopathology. e-Pub 2021. PMID: 34905283.
15. Lanke G, Stewart JM,Lee JH. Pancreatic paraganglioma diagnosed by endoscopic ultrasound-guided fine needle aspiration: A case report and review of literature. World J Gastroenterol 27(37):6322-6331, 2021. PMID: 34712035.
16. Lee JH, Kedia P, Stavropoulos S, Carr-Locke D. AGA Clinical Practice Update on Endoscopic Management of Perforations in Gastrointestinal Tract: Expert Review. Clin Gastroenterol Hepatol. e-Pub 2021. PMID: 34224876.
17. Nehme F, Lee JH. Preoperative biliary drainage for pancreatic cancer. Dig Endosc, 2021. PMID: 34275165.
18. Lee JH, Kedia P, Stavropoulos S, Carr-Locke D. AGA Clinical Practice Update on Endoscopic Management of Q1 Perforations in Gastrointestinal Tract: Expert Review. Clin Gastroenterol Hepatol S1542-3565(21):00709-6, 2021.
19. Ahmed O, Lee JH, Thompson CC, Faulx A. AGA Clinical Practice Update on The Optimal Management of the Malignant Alimentary Tract Obstruction: Expert Review. Clin Gastroenterol Hepatol 21(S1542-3565), 2021. PMID: 33813072.
20. Xu Y, Li Y, Jin J, Han G, Sun C, Pizzi MP, Huo L, Scott A, Wang Y, Ma L, Lee JH, Bhutani MS, Weston B, Vellano C, Yang L, Lin C, Kim Y, MacLeod AR, Wang L, Wang Z, Song S, Ajani JA. Correction to: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma. Mol Cancer 20(1):56, 2021. PMID: 33766033.
21. Song S, Chen Q, Li Y, Lei G, Scott A, Huo L, Li CY, Estrella JS, Correa A, Pizzi MP, Ma L, Jin J, Liu B, Wang Y, Xiao L, Hofstetter WL, Lee JH, Weston B, Bhutani M, Shanbhag N, Johnson RL, Gan B, Wei S, Ajani A. Targeting Cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma. Gut, 2021. PMID: 33487592.
22. Coronel M, Lanke G, Campbell D, Coronel E, Tzeng CD, Foo W, Lee JH. Performing endoscopic retrograde cholangiopancreatography and endoscopic ultrasound for management of malignant bile duct obstruction in a patient with a situs inverus totalis. ACC Case Rep 7(12), 2020.
23. Hao D, Siyuan H, Harada K, Pizzi MP, Lu Y, Guan P, Chen L, Wang R, Zhang S, Sewastjanow-Silva M, Abdelhakeem A, Shanbhag N, Bhutani M, Han G, Lee JH, Zhao S, Weston B, Murphy MB, Waters R, Estrella JS, Roy-Chowdhuri S, Gan O, Lee JS, Peng G, Hanash SM, Calin GA, Zhang J, Song S, Wang L, Ajani JA. Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma. Gut, 2020. PMID: 33334899.
24. Hagan KB, Carlson R, Arnold B, Nguyen L, Lee JH, Weston B, Hernandez M, Feng L, Syed T, Hagberg CA. Safety of the LMA Gastro for endoscopic retrograde cholangiopancreatography. Anesth Analg 131(5):1566-1572, 2020.
25. Harada K, Patnana M, Wang X, Iwatsuki M, Murphy MAB, Zhao M, Das P, Minsky BD, Weston B, Lee JH, Bhutani MS, Estrella JS, Shanbhag N, Ikoma N, Badgwell BD, Ajani JA. Low metabolic activity in primary gastric adenocarcinoma is associated with resistance to chemoradiation and the presence of signet ring cells. Surg Today 10(50):1223-1231, 2020. e-Pub 2020. PMID: 32409870.
26. Kumar S, Youn, YH, Lee JH. Life on a knife edge: the optimal approach to the management of perforations during endoscopic submucosal dissection (ESD). Expert Rev Gastroenterol Hepatol 14(10):965-973, 2020.
27. Hou T, Stewart JM, Lee JH, Gan Q. Solid tumor metastasis to the pancreas diagnosed using fine-needle aspiration. Am J Clin Pathol 154(5):692-699, 2020.
28. Harada K, Hwang H, Wang X, Abdelhakeem A, Iwatsuki M, Murphy MAB, Maru DM, Weston B, Lee JH, Rogers JE, Trail A, Shanbhag N, Zhao M, Bhutani MS, Nguyen QN, Swisher SG, Ikoma N, Das P, Hofstetter WL, Badgwell BD, Ajani JA. Brain metastases in patients with upper gastrointestinal cancer is associated with proximally located adenocarcinoma and lymph node metastases. Gastric Cancer 23(5):904-912, 2020.
29. Weston BR, Patel JM, Pande M, Lum PJ, Ross WA, Raju GS, Lynch PM, Coronel E, Ge PS, Lee JH. Efficacy of uncovered colonic stents for extrinsic versus intrinsic malignant large bowel obstruction. Surg Endosc. e-Pub 2020.
30. Cazacu IM, Singh BS, Chavez AAL, Koduru P, Ejaz S, Weston BR, Ross WA, Lee JH, Roy-Chowdhuri S, Bhutani MS. EUS and EUS-guided FNA/core biopsies in the evaluation of subepithelial lesions of the lower gastrointestinal tract:10-year experience. Endosc Ultrasound 9(5):329-336, 2020.
31. Harada K, Wu CC, Wang X, Mizrak Kaya D, Amlashi FG, Iwatsuki M, Blum Murphy MA, Maru DM, Weston B, Lee JH, Rogers JE, Thomas I, Shanbhag N, Bhutani MS, Hofstetter WL, Nguyen QN, Ajani JA. Total Lesion Glycolysis Assessment Identifies a Patient Fraction With a High Cure Rate Among Esophageal Adenocarcinoma Patients Treated With Definitive Chemoradiation. Ann Surg 272(2):311-318, 2020.
32. Angsuwatcharakon P, Ahmed O, Lynch PM, Lum P, Gonzalez GN, Weston B, Coronel E, Katz MHG, Folloder J, Lee JH. Management of ampullary adenomas in familial adenomatous polyposis syndrome:16 years of experience from a tertiary cancer center. Gastrointest Endosc 92(2):323-330, 2020.
33. Lee JH. How far have we come in the design of biliary stents: Are biodegradable stents ready for prime time?. Gastrointestinal Endosc 92(2):412-141, 2020.
34. Aslanian HR, Lee JH, Canto MI. AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review. Gastroenterol 159(1):358-362, 2020.
35. Campbell DR Jr, Lee JH. A comprehensive approach to the management of benign and malignant ampullary lesions: Management in hereditary and sporadic settings. Curr Gastroenterol Rep 22(9):46, 2020.
36. Song S, Li Y, Xu Y, Ma L, Pool Pizzi M, Jin J, Scott AW, Huo L, Wang Y, Lee JH, Bhutani MS, Weston B, Shanbhag ND, Johnson RL, Ajani JA. Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma. Mol Oncol 14(6):1410-1426, 2020.
37. Lanke G, Lee JH. Similarities and differences in guidelines for the management of pancreatic cysts. World J Gastroenterol 26(11):1128-114, 2020.
38. Ahmed O, Lee JH. Modern gastrointestinal endoscopic techniques for biliary tract cancers. Chin Clin Oncol 9(1):3, 2020. e-Pub 2019. PMID: 31735049.
39. Mizrak Kaya D, Nogueras Gonzalez GM, Harada K, Blum Murphy MA, Lee JH, Bhutani MS, Weston B, Thomas I, Rogers JE, Das P, Badgwell BD, Ajani JA. Efficacy of Three-Drug Induction Chemotherapy Followed by Preoperative Chemoradiation in Patients with Localized Gastric Adenocarinoma. Oncology 98(8):542-548, 2020.
40. Lopez A, Harada K, Chen HC, Bhutani MS, Weston B, Lee JH, Maru DM, Chin FW, Rogers JE, Thomas I, Amlashi FG, Blum-Murphy MA, Rice DC, Zhao M, Hofstetter WL, Nguyen Q, Ajani JA. Taxane-based or platinum-based combination chemotherapy given concurrently with radiation followed by surgery resulting in high cure rates in esophageal cancer patients.Medicine (Baltimore). Medicine (Baltimore) 99(9), 2020. PMID: 32118743.
41. Raju GS, Lum P, Abu-Sbeih H, Ross WA, Thirumurthi S, Miller E, Lynch P, Lee JH, Bhutani MS, Shafi M, Weston B, Rashid A, Wang Y, Chang GJ, Carson III R, Hagan K, Davila M, Stroehlein J. Cap-fitted endoscopic mucosal resection of > 20mm colon flat lesions followed argon plasma coagulation results in a low adenoma recurrence rate. Endosc Int Open 8(2):E115-E121, 2020.
42. Cazacu IM, Luzuriaga Chavez AA, Mendoza TR, Qiao W, Singh BS, Bokhari RH, Saftoiu A, Lee JH, Weston B, Stroehlein JR, Kim MP, G Katz MH, Maitra A, McAlliser F, Bhutani MS. Quality of life impact of EUS in patients at risk for developing pancreatic cancer. Endosc Ultrasound 9(1):53-58, 2020.
43. Mizrak Kaya D, Nogueras González GM, Harada K, Blum Murphy MA, Lee JH, Bhutani MS, Weston B, Thomas I, Rogers JE, Das P, Badgwell BD, Ajani JA. Efficacy of Three-Drug Induction Chemotherapy Followed by Preoperative Chemoradiation in Patients with Localized Gastric Adenocarcinoma. Oncology 98(8):542-548, 2020. PMID: 32434189.
44. Chen D, Menon H, Verma V, Seyedin SN, Ajani JA, Hofstetter WL, Nguyen QN, Chang JY, Gomez DR, Amini A, Swisher SG, Blum MA, Younes AI, Barsoumian HB, Erasmus JJ, Lee JH, Bhutani MS, Hess KR, Minsky BD, Welsh JW. Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer. JAMA Oncol 5(11):1597-1604, 2019. e-Pub 2019. PMID: 31529018.
45. Ahmed O, Ajani JA, Lee JH. Endoscopic management of esophageal cancer. World J Gastrointest Oncol 11(10):830-841, 2019. PMID: 31662822.
46. Xu Y, Li Y, Jin J, Han G, Sun C, Pizzi MP, Huo L, Scott A, Wang Y, Ma L, Lee JH, Bhutani MS, Weston B, Vellano C, Yang L, Lin C, Kim Y, MacLeod AR, Wang L, Wang Z, Song S, Ajani JA. LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma. Mol Cancer 18(1):141, 2019. PMID: 31601234.
47. Othman MO, Lee JH, Wang K. Clinical Practice Update on the Utility of Endoscopic Submucosal Dissection in T1b Esophageal Cancer: Expert Review. Clin Gastroenterol Hepatol 17(11):2161-2166, 2019. PMID: 31401148.
48. Cazacu IM, Luzuriaga Chavez AA, Mendoza TR, Qiao W, Singh BS, Bokhari RH, Saftoiu A, Lee JH, Weston B, Stroehlein JR, Kim MP, G Katz MH, Maitra A, McAllister F, Bhutani MS. Quality of endoscopy reporting at index colonoscopy significantly impacts outcome of subsequent EMR in patients with > 20 mm colon polyps. Endosc Ultrasound. e-Pub 2019. PMID: 31552914.
49. Koay EJ, Katz HMGk, Wang H, Wang X, Prakash L, Javle M, Shroff R, Fogelman D, Avila S, Zaid M, Elganainy D, Lee Y, Crane CH, Krishnan S, Das P, Fleming JB, Lee JE, Tamm EP, Bhosale P, Lee JH, Weston B, Maitra A, Wolff RA, Varadhachary GR. Computed tomography-based biomarker outcomes in a prospective trial of preoperative FOLFFIRINOX and Chemoradiation for borderline resectable pancreatic cancer. JCO. e-Pub 2019.
50. Lee JH, Emelogu I, Kukreja K, Ali FS, Nogueras-Gonzalez G, Lum P, Coronel E, Ross W, Raju GS, Lynch P, Thirumurthi S, Stroehlein J, Wang Y, You YN, Weston B.. Safety and efficacy of metal stents for malignant colonic obstruction in patients treated with bevacizumab. Gastrointest Endosc 90(1):116-124, 2019.
51. Harada K, Hwang H, Wang X, Abdelhakeem A, Iwatsuki M, Blum Murphy MA, Maru DM, Weston B, Lee JH, Rogers JE, Thomas I, Shanbhag N, Zhao M, Bhutani MS, Nguyen QN, Swisher SG, Ikoma N, Badgwell BD, Hofstetter WL, Ajani JA. Frequency and Implications of Paratracheal Lymph Node Metastases in Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma. Ann Surg 273(4):751-757. e-Pub 2019. PMID: 31188215.
52. Mork M, Quesada PR, Bannon S, Montiel MF, Fleming JB, Lynch PM, Bhutani MS, Lee JH, McAllister F. Pancreatic Cancer Early Detection and Interception in an Atypical Case of Peutz-Jeghers Syndrome. Pancreas 48(4):e29-e30, 2019. PMID: 30973470.
53. Gulhati P, Prakash L, Katz MHG, Wang X, Javle M, Shroff R, Fogelman D, Lee JE, Tzeng CD, Lee JH, Weston B, Tamm E, Bhosale P, Koay EJ, Maitra A, Wang H, Wolff RA, Varadhachary GR. First-line gemcitabine and Nab-Paclitaxel Chemotherapy for localized Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol 26(2):619-627, 2019. e-Pub 2018. PMID: 30324485.
54. Lee JH, Ahmed O. Endoscopic Management of Pancreatic Cancer. Surg Oncol CLin N Am 28(1):147-159, 2019.
55. Abu-Sbeith H, Ali FS, Coronel E, Chen HC, Wang X, Lum P, Shuttlesworth G, Bhutani MS, Raju GS, Lee JH, Stroehlein J, Ross WA, Wang Y. Safety of endoscopy in cancer patients with thrombocytopenia and nuetropaeni. Gastrointest Endosc S0016-5107(18):33347-9, 2018. e-Pub 2018.
56. Ikoma N, Lee JH, Bhutani MS, Ross WA, Weston B, Chiang YJ, Blum MA, Sagebiel T, Devine CE, Matamoros A Jr, Fournier K, Mansfield P, Ajani JA, Badgwell BD. Preoperative accuracy of gastric cancer staging in patient selection for preoperative therapy: race may affect accuracy of endoscopic ultrasonography. J Gastrointest Oncol 8(6):1009-101, 2018.
57. Malakorn S, Stein SL, Lee JH, You YN. Urgent Management of Obstructing Colorectal Cancer: Divert, Stent, or Resect?. J Gastrointest Surg. e-Pub 2018.
58. Gleeson FC, Lee JH, Dewitt JM. Tumor seeding associated with selected gastrointestinal endoscopic interventions. Clin Gastroenterol Hepatol 16(9):1385-1388, 2018. e-Pub 2018.
59. Cassani LS, Chouhan J, Chan C, Lanke G, Wang X, weston B, Ross WA, Raju GS, Lee JH. Biliary decompression in perihilar cholangiocarcinoma imprvoes survival: A single-center reprospective analysis. Dig Dis Sci. e-Pub 2018.
60. Lanke G, Ali FS, Lee JH. Clinical Update on the management of pseudopapillary tumor of the pancreas. World J Gastrointest Endosc 10(9):145-155, 2018.
61. DaVee T. Coronel E, Papafragkakis C, Thaiudom S, Lanke G, Chakinala R, Nogueras Gonzalez GM, Bhutani MS, Ross WA, Weston BR, Lee JH. Pancreatic cancer screening in high-risk individuals with germline genetic mutations. Gastrointest Endosc 87(6):1443-1450, 2018.
62. Oh SC, Sohn BH, Cheong JH, Kim SB, Lee JE, Park KC, Lee SH, Park JL, Park YY, Lee HS, Jang HJ, Park ES, Kim SC, Jeo J, Chu IS, Jang YJ, Mok YJ, Jung WK, Kim BH, Kim A, Cho JY, L JY, Hayash Y, Song S, Elimova E, Estralla JS, Lee JH, Bhutani MS, Lu Y, Liu W, Lee J, Kang WK, Kim S, Noh SH, Mills BG, Kim SY, Ajani JA, Lee JS. Clinical and Genomic landscape of gastric cancer with a mesenchymal phenotype. Nat Commun 9(1):1777, 2018.
63. Mizrak KD, Nogueras GG, Harada K, Amlashi FG, Thomas I, Rogers JE, Bhutani, M, Lee JH, Weston B, Minsky B, Estrella JS, Blum Murphy M, Matmoros Jr, A, Devine CE, Das P, Badgwell BD, Ajani JA. Potentially curable gastric adenocarcinoma treated without surgery. Eur J Cancer(98):23-29, 2018.
64. Amlashi FG, Wang X, Davila RE, Maru DM, Bhutani MS, Lee JH, Weston BR, Mizrak KD, Vassilakopoulou M, Harada K, Blum Murphy MA, Rice DC, Hofstetter WL, Davila M, Nguyen QN, Ajani JA. Barrett's esophagus after bimodality therapy in patients with esophageal adenocarcinoma. Oncology 95(2):81-90, 2018.
65. Elimova E, Wang X, Qiao w, Sudo K, Wadhwa R, Shiozaki H, Shimodaira Y, Planjery V, Charalampakis N, Lee JH, Weston BR, Bhutani MS, Komaki R, Rice DC, Swisher SG, Blum MA, Rogers JE, Skinner HD, Maru DM, Hofstetter wl, Ajani JA. Actionable Locoregional Relapses after therapy of localized esophageal cancer: Insights from a large cohort. Oncology 94(6):345-353, 2018.
66. Mizrak KD, Nogueras GG, Harada K, Amlashi FG, Roy-Chowdhuri S, Estrella JS, Das P, Lee JH, Weston B, Bhutani M, Matamoros Jr, A, Thomas I, Lin Q, Badgwell BD, Ajani JA. Risk of peritoneal metastases in patients who had negative peritoneal staging and received therapy for localized gastric adenocarcinoma. J Surg Oncol 117(4):678-684, 2018. e-Pub 2017.
67. Shimodaira Y, Slack RS, Harada K, Chen HC, Sagebiel T, Bhutani MS, Lee JH, Weston B, Elimova E, Lin Q, Amlashi FG, Mizrak Kaya D, Blum MA, Roth JA, Swisher SG, Skinner HD, Hofstetter WL, Rogers JE, Mares J, Thomas I, Maru DM, Komaki R, Walsh G, Ajani JA. Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial. Br J Cancer 118(3):331-337, 2018. e-Pub 2017.
68. Harada K, Wang X, Shimodaira Y, Sagebiel T, Bhutani MS, Lee JH, Weston B, Elimova E, Lin Q, Amlashi FG, Mizrak Kaya D, Lopez A, Blum Murphy MA, Roth JA, Swisher SG, Skinner HD, Hofstetter WL, Rogers JE, Thomas I, Maru DM, Komaki R, Walsh G, Ajani JA.. Early Metabolic Change after Induction Chemotherapy Predicts Histologic Response and Prognosis in Patients with Esophageal Cancer: Secondary Analysis of a Randomized Trial. Target Oncol 13(1):99-106, 2018.
69. Ajani JA, Estrella JS, Chen Q, Correa AM, Ma L, Scott AW, Jin J, Liu B, Xie M, Sudo K, Shiozaki H, Badgwell B, Weston B, Lee JH, Bhutani MS, Onodera H, Suzuki K, Suzuki A, Ding S, Hofstetter WL, Johnson RL, Bresalier RS, Song S. Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors. Br J Cancer 118(1):52-61, 2018. e-Pub 2017.
70. Ahmed O, Lee JH. Preoperative biliary drainage for pancreatic cancer. Gastrointest Interv 7(2):67-73, 2018.
71. Elimova E, Wang X, Qiao W, Sudo K, Wadhwa R, Shiozaki H, Shimodaira Y, Planjery V, Charalampakis N, Lee JH, Weston BR, Bhutani MS, Komaki R, Rice DC, Swisher SG, Blum MA, Rogers JE, Skinner HD, Maru DM, Hofstetter WL, Ajani JA. Actionable Locoregional Relapses after Therapy of Localized Esophageal Cancer: Insights from a Large Cohort. Oncology 94(6):345-353, 2018.
72. Lee JH, DaVee T. Biliary Obstruction: Endoscopic Approaches. Semin Intervent Radiol 34(4):369-375, 2017. e-Pub 2017.
73. Blum MM, Xiao L, Patel VR, Maru DM, Correa AM, Amlashi F, Liao Z, Komaki R, Lin SH, Skinner HD, Vaporciyan A, Walsh GL, Swisher SG, Sepesi B, Lee JH, Bhutani MS, Weston B, Hofstetter WL, Ajani JA. Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival-The University of Texas MD Anderson Cancer Center experience. Cancer 123(21):4106-4113, 2017. e-Pub 2017.
74. Blum Murphy M, Xiao L, Patel VR, Maru DM, Correa AM, G Amlashi F, Liao Z, Komaki R, Lin SH, Skinner HD, Vaporciyan A, Walsh GL, Swisher SG, Sepesi B, Lee JH, Bhutani MS, Weston B, Hofstetter WL, Ajani JA.. Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival-The University of Texas MD Anderson Cancer Center experience. Cancer 123(21):4106-4113, 2017.
75. Kirtane T, Cassani L, Davis D, Lee JH. Pancreatic cystic neoplasms in real-time EUS 2(12):334-335, 2017.
76. Charalampakis N, Xiao L, Lin Q, Elimova E, Shimodaira Y, Harada K, Rogers JE, Mares J, Amlashi FG, Minsky BD, Das P, Hofstetter WL, Matamoros A Jr, Sagebiel TL, Blum-Murphy MA, Lee JH, Weston B, Bhutani MS, Mansfield PF, Estrella JS, Badgwell BD, Ajani JA. Co-Morbidities rather than Age Impact Outcomes in Patients Receiving Preoperative Therapy for Gastroesophageal Adenocarcinoma. Ann Surg Oncol 24(8):2291-2301, 2017. e-Pub 2016.
77. Xi M, Xu C, Liao Z, Hofstetter WL, Blum Murphy M, Maru DM, Bhutani MS, Lee JH, Weston B, Komaki R, Lin SH. The impact of histology on recurrence patterns in esophageal cancer treated with definitive chemoradiotherapy. Radiother Oncol 124(2):318-324, 2017. e-Pub 2017.
78. Mizrak KD, Dong X, Nogueras-Gonzalez GM, Xu Y, Estrella JS, Harada K, Lopez A, Amlashi FG, Hofstetter WL, Maru DM, Nguyen QN, Lee JH, Weston B, Bhutani MS< Erasmus JJ, Thomas I, Rogers JE, Song S, Ajani JA. Post-trimodality expression levels of metadherin (MTDH) as a prognostic biomarker for esophageal adenocarcinoma patients. Med Oncol 34(8):135, 2017. e-Pub 2017.
79. Wadhwa R, Wang X, Baladandayuthapani V, Liu B, Shiozaki H, Shimodaira Y, Lin Q, Elimova E, Hofstetter WL, Swisher SG, Rice DC, Maru DM, Kalhor N, Bhutani MS, Weston B, Lee JH, Skinner HD, Scott AW, Kaya DM, Harada K, Berry D, Sog S, Ajani JA. Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patients. Br J Cancer 117(5):648-655, 2017. e-Pub 2017.
80. Rogers E, Slack RS, Che HC, Lin Q, Harada K, Estrella JS, Mizrak KD, Sagebiel T, Lee, JH, Weston B, Bhutani M, Blum M, Matamoros Jr A, Minsky B, Das P, Mansfield PF, Badgwell BD, Ajani JA. Patterns of Relapse in Patients with Localized Gastric Adenocarcinoma Who had surgery with or without adjunctive therapy: Costs and Effectivness of Surveillance. Oncotarget 8(46):81430-81440, 2017.
81. Elimova E, Slack RS, Chen HC, Planjery V, Shiozaki H, Shimodaira Y, Charalampakis N, Lin Q, Harada K, Wadhwa R, Estrella JS, Kaya DM, Sagebiel T, Lee JH, Weston B, Bhutani M, Murphy MB, Matamoros A, Minsky B, Das P, Mansfield PF, Badgwell BD, Ajani JA.. Patterns of relapse in patients with localized gastric adenocarcinoma who had surgery with or without adjunctive therapy: costs and effectiveness of surveillance. Oncotarget 8(46):81430-81440, 2017.
82. Weston BR, Ross WA, Bhutani MS, Lee JH, Pande M, Sholl AB, Krishnamurthy S. Prospective Randomized comparison of a 22G core needle using standard versus capillary suction for EUS-guided sampling of solid pancreatic masses. Endosc Int 5(6):E505-E512, 2017. e-Pub 2017.
83. Xi M, Hallemeier CL, Merrell KW, Liao Z, Murphy MAB, Ho L, Hofstetter WL, Mehran R, Lee JH, Bhutani MS, Weston B, Maru DM, Komaki R, Ajani JA, Lin SH. Recurrence risk stratification after preoperative chemoradiation of esophageal adenocarcinoma. Ann Surg 268(2):289-295, 2017. e-Pub 2017.
84. Xi M, Xu C, Liao Z, Chang JY, Gomer DR, Jeter M, Cox JD, Komaki R, Mehran R, Blum MA, Hofstetter WL, Maru DM, Bhutani MS, Lee JH, Weston B, Ajani JA, Lin SH. Comparative Outcome After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional Analysis. Int J Radiat oncol Biol Phys. e-Pub 2017.
85. Shimodaira Y, Slack RS, Harada K, Bhutani MS, Elimova E, Staerkel GA, Sneige N, Erasmus J, Shiozaki H, Charalampakis N, Planjery V, Kaya DM, Amlashi FG, Blum MA, Skinner HD, Minsky BD, Maru DM, Hofstetter WL, Swisher SG, Mares JE, Rogers JE, Lin QD, Ross WA, Weston B, Lee JH, Ajani JA. Utility of endoscopic ultrasound-guided fine-needle aspiration of regional lymph nodes that are proximal to and far from the primary distal esophageal carcinoma. Oncotarget 8(45):79356-79365, 2017. e-Pub 2017.
86. Thirumurthi S, Raju GS, Pande M, Ruiz J, Carlson R, Hagan KB, Lee JH, Ross WA. Does deep sedation with propofol affect adenoma detection rates in average risk screening colonoscopy exams?. World J of Gastrointest Endosc 9(4):177-182, 2017.
87. Lanke G, Lee JH. How best to manage gastrointestinal stromal tumor. World J Clin Oncol 8(2):135-144, 2017.
88. Welsh JW, Seyedin SN, Allen PK, Hofstetter WL, Ajani JA, Chang JY, Gomez DR, Amini A, Swisher SG, Blum MA, Younes AI, Nguyen QN, Minsky BD, Erasmus JJ, Lee JH, Bhutani M, Komaki RU. Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II Trial. J Thorac Oncol 12(2):375-382, 2017. e-Pub 2016.
89. DaVee T, Ajani JA, Lee JH. Is Endoscopic Ultrasound examination necessary in the management of esophageal cancer?. World J Gastroenterol 23(5):751-762, 2017.
90. Rayamajhi SJ, Lee J, Mittal BR, Jessop AC, Chasen B, Bhosale P. Cross sectional and nuclear medicine imaging of pancreatic insulinomas. Abdom Radiol 42(2):531-543, 2017. e-Pub 2016.
91. Cloyd JM, Katz MH, Prakash L, Varadhachary GR, Wolff RA, Shroff RT, Javle M, Fogelman D, Overman M, Crane CH, Koay EJ, Das P, Krishnan S, Minsky BD, Lee JH, Bhutani MS, Weston B, Ross W, Bhosale P, Tamm EP, Wang H, Maitra A, Kim MP, Aloia TA, Vauthey JN, Fleming JB, Abbruzzese JL, Pisters PW, Evans DB,Lee JE. Preoperative therapy and pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-year single-institution experience. J Gastrointest Surg 21(1):164-174, 2017. e-Pub 2016.
92. Coronel E, DaVee T, Lee JH. Advances in Endotherapy in Chronic Pancreatitis. Gastrointestinal Intervention 6(1):25-31, 2017.
93. Elimova E, Slack RS, Chen HC, Planjery V, Slhimodaira Y, Charalampakis N, Lin Q, Harada K, Wadhwa R, Estrella JS, Kaya DM, Sagebiel T, Lee JH, Weston B, Bhutani M, Murphy MB, Matamoros A, Minsky B, Das P, Mansfield PF, Badgwell BD, Ajani JA. Prognostic significance of Sigent Ring Cells in untreated Gastric Adenocarcinoma (GAC) after definitive therapy. Oncotarget 8(46):81430-81440, 2017.
94. Mizrak Kaya D, Nogueras-Gonzalez GM, Harada K, Amlashi FG, Roy-Chowdhuri S, Estrella JS, Das P, Lee JH, Weston B, Bhutani M, Matamoros Jr, A, Thomas I, Lin Q, Badgwell BD, Ajani JA. 101 Long-term survivors who had metastatic gastroesophageal cancer and received local consolidative therapy. Oncology 93(4):243-248, 2017. e-Pub 2017.
95. Ikoma N, Lee JH, Bhutani MS, Ross WA, Weston B, Chiang YJ, Blum M, Sagebiel T, Devine CE, Matamoros A, Fournier K, Mansfield P, Ajani JA, Badgwell BD. Preoperative accuracy of gastric cancer staging in patient selction for preoperative therapy: Race may affect EUS accuracy. J Gastrointest Oncol 8(6):1009-1017, 2017.
96. Xi M, Xu C, Liao Z, Chang JY, Gomez DR, Jeter M, Cox JD, Komaki R, Mehran R, Blum MA, Hofstetter WL, Maru DM, Bhutani MS, Lee JH, Weston B, Ajani JA, Lin SH. Comparative outcomes after definitive chemoradiotherapy using proton beam therapy versus intensity modulated radiation therapy for esophageal cancer: A retrospective, single-institutional analysis. IntJ Radiat Oncol Biol Phys 99(3):667-676, 2017.
97. Blum Murphy M, Xiao L, Patel VR, Maru DM, Correa AM, G Amlashi F, Liao Z, Komaki R, Lin SH, Skinner HD, Vaporciyan A, Walsh GL, Swisher SG, Lee JH, Bhutani MS, Weston B, Hofstetter, Ajani JA.. Pathological complete response with esophageal cancer after the trimodality approach: The association with baseline variable and survival – The University of Texas MD Anderson Cancer Center experience. Cancer 123(21):4106-4113, 2017.
98. Lanke G, Lee JH. How best manage gastrointestinal tumor. World J Clin Oncol 8(2):135-144, 2017.
99. DaVee T, Ajani JA, Lee JH. Is endoscopic ultrasound examination necessary in the management of esophageal cancer. World J. Gastroenterol 23(5):751-762, 2017.
100. Cassani LS, Lanke G, Chen HC, Wang X, Lynch P, Lee JH. Comparison of nonampullary duodenal adenomas in patients with familial adenomatous polyposis versus patients with sporadic adenomas. Gastrointest Endosc 85(4):803-812, 2017.
101. Wadhwa R, Wang X, Baladandayuthapani V, Liu B, Shizaki H, Shimodaira Y, Lin Q, Elimova E, Hofstetter WL, Swisher SG, Rice DC, Maru DM, Kalhor N, Bhutani MS, Weston B, b|Lee JH, Skinner HD, Scott AW, Kaya DM, Harada K, Berry D, Song S, Ajani JA. Nuclear expression of Gli-1 is (lIs) corre 5:648-655, 2017.
102. Papafragkakis C, Lee JH. Comprehensive management of cholangiocarcinoma: Part I. Diagnosis. Gastrointest Interv 6(2):85-93, 2017.
103. Papafragkakis C, Lee JH. Comprehensive management of cholangiocarcinoma: Part II. Treatment 6(2):94-104, 2017.
104. Lee JH, Cassani LS, Bhosale P, Ross WA. The endoscopist's role in the diagnosis and management of pancreatic cancer. Expert Review of Gastroenterology & Hepatology 10(9):1027-39, 2016. e-Pub 2016. PMID: 27087265.
105. Cassani LS, Lanke G, Chen HC, Wang X, Lynch P, Lee JH. Comparison of nonampullary duodenal adenomas in patients with familial adenomatous polyposis versus patients with sporadic adenomas. Gastrointest Endosc s0016-5107(16):30472-2, 2016.
106. Tamm EP, Bhosale P, Lee JH, Rohren EM. State-of-the-art imaging of pancreatic neuroendocrine tumors. Surg Oncol Clin N Am 25(2):375-400, 2016.
107. Sudo K, Wang X, Xiao L, Wadhwa R, Shiozaki H, Elimova E, Rice DC, Lee JH, Weston B, Bhutani MS, Hiremath A, Charalampakis N, Komaki R, Blum MA, Swisher SG, Maru DM, Skinner HD, Garris JL, Rogers JE, Hofstetter WL, Ajani JA. A Nomogram to Predict Distant Metastases After Multimodality Therapy for Patients With Localized Esophageal Cancer. J Natl Compr Canc Netw 14(2):173-9, 2016.
108. Krishna SG, Bhattacharya A, Li F, Ross WA, Ladha H, Porter K, Atiq M, Bhutani MS, Lee JH. Diagnostic Differentiation of Pancreatic Neuroendocrine Tumor from Other Neoplastic solid pancreatic lesions during endoscopic Ultrasound-guided Fine-Needle aspiration. Pancreas 45(3):394-400, 2016.
109. Sudo K, Wang X, Xiao L, Wadhwa R, Shiozaki H, Elimova E, Rice DC, Lee JH, Weston B, Bhutani MS, Hiremath , Charalampakis N, Komaki R, Blum MA, Swisher SG, Maru DM, Skinner HD, Garris JL, Rogers JE, Hofstetter WL, Ajani JA. A nomogram to predict distant metastases after multimodality therapy of patients with localized esophageal cancer. JNCCN 14(2):173-9, 2016.
110. Shiozaki H, Elimova E, Slack RS, Chen HC, Staerkel GA, Sneige N, Shimodaira Y, Sagebiel T, Lee JH, Bhutani MS, Das P, Mansfield PF, Estrella JS, Badgwell BD, Ajani JA. Prognosis of gastric adenocarcinoma patients with various burdens of peritoneal metastases. J Surg Oncol 113(1):29-35, 2016. e-Pub 2015.
111. Charalampakis N, Nogueras-Gonzalez G, Elimova E, Wadhwa R, Shiozaki H, Shimodaira Y, Blum M, Rogers J, Harada K, Matamoros A, Sagebiel T, Das P, Minsky B, Lee J, Weston B, Bhutani M, Estrella J, Badgwell B, Ajani J. The proportion of signet ring cell component in patients with localized gastric adenocarcinoma correlates with the degree of response to preoperative chemoradiation. Oncology 90(5):239-47, 2016. e-Pub 2016.
112. Krishna SG, Lee JH. Appraisal of Needle-based confocal laser endomicroscopy in the diagnosis of pancreatic cysts. World Journal of Gastro 22(4):1701-1710, 2016.
113. Shiozaki H, Slack RS, Chen HC, Elimova E, Planjery V, Charalampakis N, Wadhwa R, Shimodaira Y, Skinner H, Lee JH, Weston B, Bhutani MS, Blum-Murphy M, Rogers JE, Maru DM, Matamoros A, Sagebiel T, Estrella JS, Das P, Hofstetter WL, Mares JE, Kaya DM, Harada K, Lin Q, Minsky BD, Badgwell BD, Ajani JA. Metastatic Gastroesophageal Adenocarcinoma Patients Treated with Systemic Therapy Followed by Consolidative local Therapy: A Nomogram Associated with Long-term Survivors. Oncology 91(1):55-60, 2016.
114. Raju GS, Lum PH, Ross WA, Thirumurthi S, Miller E, Lynch PM, Lee JH, Bhutani MS, Shafi MA, Weston BR, Pande M, Bresalier RS, Rashid A, Mishra L, Davila ML, Stroehlein JR. Outcome of EMR as an alternative to surgery in patients with complex colon polyps. Gastrointest Endosc 84(2):315, 2016.
115. Lanke G, Agarwal A, b|Lee JH. How to manage gastric polyps. Gastrointest Interv 5:159-169, 2016.
116. Shiozaki H, Slack RS, Chen HC, Elimova E, Planjery V, Charalampakis N, Wadhwa R, Shimodaira Y, Skinner H, Lee JH, Weston B, Bhutani MS, Blum-Murphy M, Rogers JE, Maru DM, Matamoros A Jr, Sagebiel T, Estrella JS, Das P, Hofstetter WL, Mares JE, Mizrak Kaya D, Harada K, Lin Q, Minsky BD, Badgwell BD, Ajani JA. Metastatic Gastroesophageal Adenocarcinoma Patients Treated with Systemic Therapy Followed by Consolidative Local Therapy: A Nomogram Associated with Long-Term Survivors. Oncology 91(1):55-60, 2016.
117. Elimova E, Wang X, Etchebehere E, Shiozaki H, Shimodaira Y, Wadhwa R, Planjery V, Charalampakis N, Blum MA, Hofstetter W, Lee JH, Weston BR, Bhutani MS, Rogers JE, Maru D, Skinner HD, Macapinlac HA, Ajani JA. 18-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patients. Eur J Cancer 51(17):2545-52, 2015. e-Pub 2015.
118. Krishna SG, Bhattacharya A, Ross WA, Ladha H, Porter K, Bhutani MS, Lee JH. Pretest prediction and diagnosis of metastatic lesions to the pancreas by endoscopic ultrasound-guided fine needle aspiration. J Gastroenterol Hepatol 30(10):1552-60, 2015. e-Pub 2015.
119. Raju GS, Lum PH, Slack R, Thirumurthi SI, Lynch PM, Miller E, Weston BR, Davila ML, Bhutani MS, Shafi MA, Bresalier RS, Dekovich AA, Lee JH, Guha S, Pande M, Blechacz B, Rashid A, Routbort M, Shuttlesworth G, Mishra L, Stroehlein JR, Ross WA. Natural Language Processing As an Alternative to Manual Reporting of Colonoscopy Quality Metrics. Gastrointest Endosc 82(3):512-9, 2015. e-Pub 2015.
120. Litton JK, Lee JH, Arun BK. Reply to BRCA2-associated pancreatic cancer and current screening guidelines. Cancer 121(17):3047, 2015. e-Pub 2015. PMID: 26018033.
121. Ghouri YA, Krishna SG, Kundu UR, Bhutani MS, Lee JH, Ross WA. A Case Series and Literature Review of Merkel Cell Carcinoma Metastasizing to Pancreas. Dig Dis Sci 60(6):1805-12, 2015. e-Pub 2015.
122. Ghouri YA, Krishna SG, Kundu UR, Bhutani MS, Lee JH, Ross WA. Erratum to: A case Series and Literature Review of Merkel Cell Carcinoma Metastasizing to pancreas. Dig Dis Sci 60(7):2211, 2015. e-Pub 2015.
123. Bektas M, Krishna SG, Ross WA, Weston B, Katz MH, Fleming JB, Lee JH, Bhutani MS. Prevalence of extra-pancreatic cysts in patients with cystic pancreatic lesions detected by endoscopic ultrasound. Endosc Ultrasound 4(3):219-24, 2015.
124. Cassani L, Lee JH. Management of malignant distal biliary obstruction. Gastrointestinal Intervention 4(1):15-20, 2015. e-Pub 2015.
125. Eshleman JR, Norris AL, Sadakari Y, Debeljak M, Borges M, Harrington C, Lin E, Brant A, Brakley T, Almario JA, Topazian M, Farrell J, Syngal S, Lee JH J, Hruban RH, Kanda M, Canato MI, Goggins M. KRAS and GNAS Mutations in Pancreatic Juice Collected From the Duodenum of Patients at High Risk for Neoplasia Undergoing Endoscopic Ultrasound. Clin Gastroenterol Hepatol 13(5):963-9, 2015. e-Pub 2014.
126. Ross WA, Thirumurthi S, Lynch PM, Rashid A, Pande M, Shafi MA, Lee JH, Raju GS. Detection rates of premalignant polyps during screening colonoscopy: Time to revise quality standards?. Gastrointest Endosc 81(3):567-74, 2015. e-Pub 2015.
127. Gavini H, Lee JH. Endoscopic Ultrasound-guided Endotherapy. J Clin Gastroenterol 49(3):185-93, 2015. e-Pub 2014.
128. Neishboori N, Wadhwa R, Nogueras-Gonzalez G, Elimova E, Shiozaki H, Sudo K, Charalampakis N, Hiremath A, Lee J, Bhutani M, Weston B, Blum M, Rogers J, Garris J, Rice D, Komaki R, Swisher S, Skinner H, Hofstetter W, Ajani J. Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation: Its Clinical Implications. Oncology 89(2):65-9, 2015.
129. Krishna S, Li F, Bhattacharya A, Ladha H, Porter K, Singh A, Ross WA, Bhutani MS, Lee, JH. Differentiation of pancreatic ductal adenocarcinoma from other neoplastic solid pancreatic lesions: a tertiary oncology center experience. Gastro Endosc 81(2):370-9, 2015. e-Pub 2014.
130. Shiozaki H, Slack R, Sudo K, Elimova E, Wadhwa R, Chen HC, Skinner HD, Komaki R, Lee JH, Weston B, Bhutani MS, Blum MA, Rogers JE, Maru DM, Hofstetter WL, Ajani JA. Geographic Distribution of Regional Metastatic Nodes Affects the Outcome of Trimodality-Eligible Patients with Esophageal Adenocarcinoma. Oncology 88(6):332-6. e-Pub 2015.
131. Shin EJ, Topazian M, Goggins MG, Syngal S, Saltzman JR, Lee JH, Farrell JJ, Canto MI. Linear-array EUS improves detection of pancreatic lesions in high-risk individuals: a randomized tandem study. Gastrointest Endosc 82(5):812-8, 2015. e-Pub 2015.
132. Elimova E, Wang X, Etchebehere E, Shiozaki H, Shimodaira Y, Wadhwa R, Planjery V, Charalampakis N, Blum MA, Hofstetter W, Lee JH, Weston BR, Bhutani MS, Rogers JE, Maru D, Skinner HD, Macapinlac HA, Ajani JA. Importance of surveillance and success of salvage strategies after definitive chemoradiation in patients with esophageal cancer. Eur J Cancer 51(17):2545-52, 2015. e-Pub 2015.
133. Charalampakis N, Xiao L, Elimova E, Wadhwa R, Shiozaki H, Shimodaira Y, Blum MA, Planjery V, Rogers JE, Matamoros A Jr, Sagebiel T, Das P, Lee JH, Bhutani MS, Weston B, Estrella JS, Badgwell BD, Ajani JA. Initial Standardized Uptake value of Positron Emission Tomography Influences the Prognosis of Patients with Localized Gastric Adenocarcinoma Treated Preoperatively. Oncology 89(6):305-10, 2015. e-Pub 2015.
134. Gavini H, Arukala VD, Stewart J, Lee JH. Medulloblastoma Metastatic to the pancreas: a case report. Gastrointestinal Intervention 3(2):116-119, 2014.
135. Skinner HD, Lee JH, Bhutani MS, Weston B, Hofstetter W, Komaki R, Shiozaki H, Wadhwa R, Sudo K, Elimova E, Song S, Ye Y, Huang M, Ajani J, Wu X. A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma. Cancer 120(23):3635-41, 2014.
136. Sudo K, Xiao L, Wadhwa R, Shiozaki H, Elimova E, Taketa T, Blum MA, Lee JH, Bhutani MS, Weston B, Ross WA, Komaki R, Rice DC, Swisher SG, Hofstetter WL, Maru DM, Skinner HD, Ajani JA. Importance of Surveillance and Success of Salvage Strategies after definitive chemoradiation in patients with esophageal cancer. J Clin Oncol 32(30):3400-5, 2014. e-Pub 2014.
137. Krishna SG, Rao BB, Thirumurthi S, Lee JH, Ramireddy S, Guindani M, Ross WA. Safety of endoscopic interventions in patients with thrombocytopenia. Gastrointest Endosc 80(3):425-34, 2014. e-Pub 2014.
138. Song S, Ajani JA, Honjo S, Maru DM, Ailing S, Heallen TR, Xiao L, Hofstetter WL, Weston B, Lee JH, Wadhwa R, Sudo Kazuki, Yao Y, Martin J, Hung MC, Johnson RL. The Hippo Coactivator YAP1 Upregulates SOX9 and Endows Cancer Stem Cell Properties in non-tumorigenetic cells and esophageal cancer cells. Cancer Res 74(15):4170-82, 2014. e-Pub 2014.
139. Taketa T, Sudo K, Correa AM, Wadhwa R, Shiozaki H, Elimova E. Campagna MC, Blum MA, Skinner HD, Komaki RU, Lee JH, Bhutani MS, Weston BR, Rice DC, Swisher SG, Maru DM, Hofstetter WL, Ajani JA. Post-chemoradiation surgical pathology stage can customize the surveillance strategy in patients with esophageal adenocarcinoma. J Natl Compr Canc Netw 12(8):1139-44, 2014.
140. Cuellar SL, Carter BW, Macapinlac HA, Ajani JA, Komaki R, Welsh JW, Lee JH, Swisher SG, Correa AM, Erasmus JJ, Hofstetter WL. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?. J Thorac Oncol 9(8):1202-6, 2014.
141. Song S, Ajani JA, Honjo S, Maru DM, Chen Q, Scott AW, Heallen TR, Xiao L, Hofstetter WL, Weston B, Lee JH, Wadhwa R, Sudo K, Stroehlein JR, Martin JF, Hung MC, Johnson RL. Hippo coactivator YAP1 upregulates SOX9 and endows esophageal cancer cells with stem-like properties. Cancer Res 74(15):4170-82, 2014.
142. Shiozaki H, Sudo K, Xiao L, Wadhwa R, Elimova E, Hofstetter WL, Skinner HD, Lee JH, Weston B, Bhutani MS, Maru DM, Blum MA, Ajani JA. Distribution and timing of distant metastasis after local therapy of patients with esophageal and esophagogastric junction cancer. Oncology 86(5-6):336-339, 2014.
143. Krishna SG, Rao BB, Lee JH. Endoscopic sonography and sonographically guided fine-needle aspiration biopsy in the diagnosis of unusual pancreatic metastases from synovial sarcoma. J Clin Ultrasound 42(3):180-2, 2014. e-Pub 2013.
144. Ajani JA, Wang X, Song S, Sudo K, Wadhwa R, Hofstetter WL, Komaki R, Dipen M, Lee JH, Bhutani M, Weston B, Baladandayuthapani V, Yao Y, Skinner H, Johnson RL, Berry D. ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients. Molecular Oncology 8(1):142-9, 2014. e-Pub 2013.
145. Amini A, Ajani J, Komaki R, Allen PK, Minsky BD, Blum M, Xiao L, Suzuki A, Hofstetter W, Swisher S, Gomez D, Liao Z, Lee JH, Bhutani MS, Welsh JW. Factors associated with local-regional failure after definitive chemoradiation for locally advanced esophageal cancer. Ann Surg Oncol 21(1):306-14, 2014.
146. Shiozaki H, Sudo K, Xiao L, Wadhaw R, Elimova E, Hofstetter WL, Skinner HD, Lee JH, Weston B, Bhutani MS, Blum MA, Maru DM, Ajani JA. Distribution and timing of distant metastasis after local therapy in a large cohort of patients with esophageal and esophagogastric junction cancer. Oncology 86(5-6):336-9, 2014.
147. Sudo K, Taketa T, Correa AM, Campagna MC, Wadhwa R, Blum MA, Komaki R, Lee JH, Bhutani MS, Weston B, SKinner HD, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Locoregional failure rate after preoperative chemoradiation of esophageal adenocarcinoma and the outcomes of salvage strategies. J Clin Oncol 31(34):4306-10, 2013. e-Pub 2013.
148. Ajani JA, Xiao L, Roth JA, Hofstetter WL, Walsh GL, Komaki R, Liao Z, Rice DC, Vaporciyan AA, Dipen MM, Lee JH, Bhutani M, Eid A, Yao JC, Phan A, Halpin AK, Akihiro S, Taketa T, Thall PF, Swisher SG. A Phase 2 Randomized Trial of Induction Chemotherapy versus no induction Chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer. Journal of Clinical Oncology 24(11):2844-9, 2013. e-Pub 2013.
149. Suzuki A, Xiao L, Taketa T, Sudo K, Wadhwa R, Blum MA, Skinner H, Komaki R, Weston B, Lee JH, Bhutani MS, Rice DC, Maru DM, Erasmu J, Swisher SG, Hofstetter WL, Ajani JA. Results of the baseline positron emission tomography can customize therapy of localized esophageal adenocarcinoma in Patients who achieve a clinical complete response after chemoradiation. Annals of Oncology 24(1):2854-9, 2013. e-Pub 2013.
150. Suzuki A, Xiao L, Taketa T, Sudo K, Wadhwa R, Blum MA, Skinner H, Komaki R, Weston B, Lee JH, Bhutani MS, Rice DC, Maru DM, Erasmus J, Swisher SG, Hofstetter WL, Ajani JA. Results of the baseline positron emission tomography can customize therapy of localized esophageal adenocarcinoma patients who achieve a clinical complete response after chemoradiation. Ann Oncol 24(11):2854-9, 2013.
151. Wadhwa R, Taketa T, Correa A, Sudo K, Campagna MC, Blum Murphy M, Komaki R, Skinner H, Lee JH, Bhutani M, Weston B, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Incidence of Brain Metastases after Trimodality Therapy in Patients with Esophageal or Gastroesophageal Cancer: Implications for Screening and Surveillance. Oncology 85(4):204-207, 2013.
152. Francis AM, Sepesi B, Correa AM, Blum MA, Erasmus JJ, Lee JH, Maru DM, Mehra RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Welsh JW, Swisher SG, Hofstetter WL. The influence of histopathologic tumor viability on Long-term survival and recurrence rates following neoadjuvant therapy for esophageal adenocarcinoma. Ann Surg 258(3):500-7, 2013.
153. Kanda M, Knight S, Topazian MD, Syngal S, Farrell J, Lee JH, Kamel I, Lennon AM, Borges M, Young A, Fujiwara S, Seike J, Eshleman J, Hruban RH, Canto M, Goggins. Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts. Gut 62(7):1024-33, 2013. e-Pub 2012. PMID: 22859495.
154. Taketa T, Xiao L, Suzuki A, Wadhwa R, Blum M, Lee JH, Weston B, Bhutani M, Skinner H, Komaki R, Maru D, Rice D, Swisher S, Hofstetter W, Ajani JA. Propensity-based Matching between Esophagogastric Cancer Patients Who Had Surgery and Who Declined Surgery after Preoperative Chemoradiation. Oncology 85(2):95-99, 2013.
155. Kochar R, Atiq M, Lee JH, Landon G, Mansfield PF, Bhutani MS. Giant Hepatic Hemangioma masquerading as a gastric subepithelial tumor. Gastroenterol Hepatol 9(6):396-8, 2013.
156. Suzuki R, Lee JH, Krishna SG, Ramireddy S, Qiao W, Weston B, Ross WA, Bhutani MS. Repeat endoscopic ultrasound-guided fine needle aspiration for solid pancreatic lesions at a tertiary referral center will alter the initial inconclusive result. J Gastrointestin Liver Dis 22(2):183-7, 2013.
157. Cheedella NK, Suzuki A, Xiao L, Hofstetter WL, Maru DM, Taketa T, Sudo K, Blum MA, Lin SH, Welch J, Lee JH, Bhutani MS, Rice DC, Vaporciyan AA, Swisher SG, Ajani JA. Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: Analysis in a large cohort. Ann Oncol 24(5):1262-6, 2013. e-Pub 2012.
158. Atiq M, Suzuki R, Khan AS, Krishna SG, Ridgway TM, Guha S, Hernandez LV, Nealon WH, Lee JH, Bhutani MS. Clinical decision making in the management of pancreatic cystic neoplasms. Expert Rev Gastroenterol Hepatol 7(4):353-60, 2013.
159. Atiq M, Bhutani MS, Ross WA, Raju GS, Gong Y, Tamm EP, Javle M, Wang X, Lee JH. Role of Endoscopic Ultrasound in Evaluation of Metastatic Lesions to the Pancreas: A tertiary cancer center experience. Pancreas 42(3):516-23, 2013. e-Pub 2012.
160. Canto MI, Harinck F, Huban RH, Offerhaus GJ, Poley JW, Kamel I, Nio Y, Schulick RS, Bassi C, Kluijt I, Levy MJ, Chak A, Fockens P, Goggins M, Bruno M; International Cancer of the Pancreas Screening (CAPS) Consortium. International Cancer of the Pancreas Screening (CAPS) Consortium Summit on the Management of Patients with Increased Risk for Familial Pancreatic Cancer. Gut 62(3):339-47, 2013. e-Pub 2012. PMID: 23135763.
161. Wang W, Shpaner A, Krishna SG, Ross WA, Bhutani MS, Tamm EP, Raju GS, Xiao L, Wolff RA, Fleming JB, Lee JH. Use of EUS-FNA in diagnosing pancreatic neoplasm without a definitive mass on CT. Gastrointest Endosc 78(1):73-80, 2013.
162. Lee JH, Krishna SG, Singh A, Ladha HS, Slack RS, Ramireddy S, Raju GS, Davila M, Ross WA. Comparison of the utility of covered metal stents versus uncovered metal stents in the management of malignant biliary strictures in 749 patients. Gastrointest Endosc 78(2):312-24, 2013.
163. Singh A and Lee JH. Self-expanding metal stents for preoperative biliary drainage in patients receiving neoadjuvant therapy for pancreatic cancer. Journ of Gastrointest Oncology 3(4):304-5, 2012.
164. Hayashi Y, Xiao L, Suzuki A, Blum MA, Sabloff B, Taketa T, Maru DM, Welsh J, Lin SH, Weston B, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Ajani JA. A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer. Eur J Cancer 48(18):3396-404, 2012.
165. Murphy MA, Taketa T, Sudo K, Lee JH, Ajani JA. Surveillance for esophageal cancer: does it make sense?. J Natl Compr Canc Netw 10(12):1590-2, 2012.
166. Singh A, Ross W, Bhattacharya A, Xiao L, Dekovich A, Davila M, Raju G, Lee JE, Fleming JB, Lee JH. Gastrojejunostomy vs. enteral self-expanding metal stent placement in patients with malignant gastric outlet obstruction. Gastrointest Intervention 3(4):304-5, 2012.
167. Kanda M, Sadakri Y, Borges M, Topazian M, Farrell J, Syngal S, Lee J, Kamel I, Lennon AM, Knight S, Fujiwar S, Hruban RH, Canto MI, Goggins M. Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia. Clinical Gastroenterology and Hepatology S1542-3565(12):1413-9, 2012.
168. Ajani AJ, Correa AM, Hofstetter WL, Rice DC, Blum MA, Suzuki A, Taketa T, Welsh J, Lin SH, Lee JH, Bhutani MS, Ross WA, Maru M, Macapinlac HA, Erasmus J, Komaki R, Mehran RJ, Vaporciyan AA, Swisher SG. Clinical Parameters Model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer. Ann Oncol 23(10):2638-42, 2012. e-Pub 2012.
169. Marks JL, Hofstetter W, Correa AM, Mehran RJ, Rice D, Roth J, Walsh G, Vaporciyan A, Erasmus J, Change J, Maru D, Lee JH, Ajani JA, Swisher SG. Salvage esophagectomy after failed definitive chemoradiation for esophageal adenocarcinoma. Ann Thorac Surg 94(4):1126-32, 2012. e-Pub 2012.
170. Taketa T, Correa AM, Suzuki A, Blum MA, Chien P, Lee JH, Welsh J, Lin SH, Maru DM, Erasmus JJ, Bhutani MS, Weston B, Ross WA, Rice DC, Vaporciyan AA, Swisher SG, Hofstetter WL, Ajani JA. Outcome of Trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiation. Oncology 83(5):300-4, 2012.
171. Saftiou A, Bhutani MS, Vilmann P, Surlin V, Uthamanthil RK, Lee JH, Bektas M, Singh H, Ghenonea DI, Patrascu S, Gupta V, Katz MH, Fleming JB. Feasibility study of EUS-NOTES as a novel approach for pancreatic cancer staging and therapy: an international collaborative study. Hepatogastroenterology 6(60):121, 2012.
172. Tamm EP, Balachandran A, Bhosale PR, Katz MH, Fleming JB, Lee JH, Varadhachary GR. Imaging of pancreatic adenocarcinoma: update on staging/resectability. Radiol Clin North Am 50(3):407-28, 2012. e-Pub 2012.
173. Canto MI, Hruban RR, Fishman EK, Kamel IR, Schulick R, Zhang A, Topazian M, Takahashi N, Fletcher J, Petersen G, Klein AP, Axilbund J, Griffin C, Syngal S, Saltzman JR, Mortele KJ, Lee JH, Tamm E, Vikram R, Bhosale P, Margolis D, Farrell J, Goggins M. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology 142(4):796-804, 2012.
174. Atiq M, Gong Y, Raju GS, Lee JH. Pancreatic Endocrine Microadenomatosis in a patient with oculofaciocardiodental (OFCD) syndrome. Pancreas 41(2):327-9, 2012. PMID: 22343980.
175. Kountourakis P, Ajani JA, Davila M, Lee JH, Bhutani MS, Izzo JG. Barrett's esophagus: a Review of biology and therapeutic approaches. Gastrointest Cancer Res 5(2):49-57, 2012.
176. Suzuki A, Xiao L, Hayashi Y, Blum MA, Welsh JW, Lin SH, Lee JH, Bhutani MS, Weston B, Maru DM, Rice DC, Hofstetter WL, Erasmus J, Swisher SG, Ajani JA. Nomograms for prognostication of outcome in patients with esophageal and gastroesophageal carcinoma undergoing definitive chemoradiotherapy. Oncology 82(2):108-113, 2012. PMID: 22328056.
177. Thosani N, Singh H, Kapadia A, Ochi N, Lee JH, Ajani J, Swisher SG, Hofstetter WL, Guha S, Bhutani MS. Diagnostic accuracy of EUS in differentiating mucosal versus submucosal invasion of superficial esophageal cancers; a systematic review and meta-analysis. Gastrointest Endosc 75(2):242-53, 2012. e-Pub 2011.
178. Harvin JA, Lahat G, Correa AM, Lee, JH, Maru D, Ajani J, Marom EM, Welsh J, Bhutani MS, Walsh G, Roth J, Mehra R, Vaporciyan A, Rice D, Swisher S, Hofstetter W. Neoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinoma: significance of microscopically positive circumferential radial margins. J Thorac Cardiovasc Surg 143(2):412-20, 2012. e-Pub 2011.
179. Lin SH, Myles BH, Wang L, Thall PF, Vaporciyan AA, Mehran RJ, Swisher S, b|Lee JH, Bhutani MS, Maru D, Ajani JA, Cox JD, Komaki R, Liao ZX. Propensity score-based comparison of outcomes with 3D conformal radiotherapy (3D-CRT) versus intensity-modulated radiation therapy (IMRT) in treatment of esophageal cancer. J Clin Oncol 30(4_suppl):66, 2012.
180. Jaganmohan S, Lee JH. Self-expandable metal stents in malignant biliary obstruction. Expert Review. Gastroenterology & Hepatology 6(1):105-14, 2012.
181. Jaganmohan S, Lynch PM, Raju RM, Ross WA, Lee JE, Raju GS, Bhutani MS, Fleming JB, Lee JH. Endoscopic management of duodenal adenomas in familial adenomatous polyposis- A single center experience. Dig Dis Sci 57(3):732-7, 2012. e-Pub 2011.
182. Atiq M, Bhutani MS, Bektas M, Lee JE, Gong Y, Tamm EP, Shah CP, Ross WA, Yao J, Raju GS, Wang X, Lee JH. EUS-FNA pancreatic neuroendocrine Tumors: A tertiary cancer center experience. Dig Dis Sci 57(3):791-800, 2012. e-Pub 2011.
183. Amini A, Xiao L, Allen PK, Suzuki A, Hayashi Y, Liao Z, Hofstetter W, Crane C, Komaki R, Bhutani MS, Lee JH, Ajani JA, Welsh H. Celiac Node Failure Patterns after definitive chemoradiation for esophageal cancer in the modern era. Int J Radiat Oncol Biol Phys 83(2):e231-9, 2012. e-Pub 2012.
184. Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Mehran RJ, Rice DC, Suzuki A, Lee JH, Bhutani MS, Welsh J, Lin SH, Maru DM, Swisher SG, Ajani JA. Patients with high body mass index tend to have lower stage of esophageal carcinoma at diagnosis. Dis Esophagus 25(7):614-22, 2012.
185. Canto MI, Hruban RH, Fishman EK, Kamel IR, Schulick R, Zhang Z, Topazian M, Takahashi N, Fletcher J, Petersen G, Klein AP, Axilbund J, Griffin C, Syngal S, Saltzman JR, Mortele KJ, Lee JH, Tamm E, Vikram R, Bhosale P, Margolis D, Farrell J, Goggins M. American Cancer of the Pancreas screening (CAPS) consortium, frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology 142(4):796-804, 2012.
186. Suzuki A, Xiao L, Taketa T, Blum MA, Matamoros A Jr, Chien PL, Mansfield PF, Fournier KF, Weston B, Lee JH, Bhutani MS, Estrella JS, Delclos ME, Krishnan S, Das P, Ajani JA. Localized gastric cancer treated with chemoradiation without surgery: UTMD Anderson Cancer Center experience. Oncology 82(6):347-51, 2012. e-Pub 2012.
187. Lee JH, Singh A. Difficult endoscopic retrograde cholangiopancreatography in cancer patients. Gastrointest interv 1:19-24, 2012.
188. Suzuki A, Xiao L, Taketa T, Blum MA, Matamoros A Jr, Chien PL, Mansfield PF, Fournier KF, Weston B, Lee JH, Bhutani MS, Estrella JS, Delclos ME, Krishnan S, Das P, Ajani JA. Localized gastric cancer treated with chemoradation without surgery: UTMD Anderson Cancer Center experience. Oncology 82(6):347-51, 2012.
189. Singal AK, Ross WA, Guturu P, Varadhachary G, Javle M, Jaganmohan S, Raju R, Fleming J, Raju GS, Kuo YF, Lee JH. Self-expanding metal stents for biliary drainage in patients with resectable pancreatic cancer: Single-center experience with 79 cases. Dig Dis and Sci 56(12):3678-84, 2011. e-Pub 2011.
190. Suzuki A, Xiao L, Hayashi Y, Macapinlac HA, Welsh J, Lin SH, Lee JH, Bhutani MS, Maru DM, Hofstetter WL, Swisher SG, Ajani JA. Prognostic significance of baseline positron emission tonography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapy. Cancer 117(21):4823-33, 2011. e-Pub 2011.
191. Ioncica AM, Atiq M, Lee JH, Saftoiu A, Bhutani MS. Gastric and pancreatic metastases from pleomorphic lung carcinoma. Endoscopy 43(Suppl 2):E317-8, 2011. e-Pub 2011.
192. Kim HN, Alouis AM, Lee JH, Qiao W, Xiao L, Ross WA. Role of ERCP in patients after hematopoietic stem cell transplantation. Gastrointest Endosc 74(4):817-24, 2011. e-Pub 2011.
193. Krishna S, Lee JH. Endosonography in solid and cystic pancreatic tumors. Journal of Interventional Gastroenterology 1(4):193-201, 2011.
194. Atiq M, Bhutani MS, Bektas M, Lee JE, Gong Y, Tamm EP, Shah CP, Ross WA, Yao J, Raju GS, Wang X, Lee JH. EUS-FNA for pancreatic neuroendocrine tumors: a tertiary cancer center experience. Dig Dis Sci 57(3):791-800, 2011.
195. Estrella JS, Hofstetter WL, Correa A, Swisher SG, Ajani JA, Lee JH, Bhutani M, Abraham S, Rashid A. Duplicated muscularis mucosa invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma. Am journ of surg path 35(7):1045-53, 2011.
196. Raju RP, Jaganmohan SR, Ross WA, Davila M, Javle M, Raju GS, Lee JH. Optimal palliation of inoperable hilar cholangiocarcinoma: Comparative assessment of the efficacy of plastic and self-expanding metal stents. Dig Dis and Sci 56(5):1557-64, 2011. e-Pub 2011. PMID: 212221566.
197. Kountourakis P, Correa AM, Hofstetter WL, Lee JH, Bhutani MS, Rice DC, Komaki R, Maru DM, Ross WA, Vaporciyan A, Swisher SG, Ajani JA. Combined Modality Therapy of cT2N0M0 Esophageal Cancer: UT MD Anderson Cancer Center Experience. Cancer 117(5):925-30, 2011. e-Pub 2010.
198. Lee JH. Self-expandable metal stents for malignant distal biliary strictures. Gastrointest Endoscopy Clin N Am(21):463-480, 2011.
199. Welsh J, Amini A, Likhacheva A, Erasmus JJ, Gomez D, Davila M, Mehran RJ, Komaki R, Liao Z, Hofstetter WL, Lee JH, Bhutani MS, Ajani JA. Update: modern approaches to the treatment of localized esophageal cancer. Curr Oncol Rep 13(3):157-67, 2011.
200. Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Lee JH, Bhutani MS, Dekovich A, Swisher SG, Ajani JA. The influence of High Body Mass Index on Prognosis of Patients with Esophageal Carcinoma Following Surgery as Primary Therapy. Cancer 116(24):5619-27, 2010.
201. Weston BR, Ross WA, Liu J, Lee JH. Clinical outcomes of nitinol and stainless steel uncovered metal stents for malignant biliary strictures. Is there a difference?. Gastrointest Endosc 72(6):1195-200, 2010.
202. Lee JH, Ross WA, Davila R, Chang G, Lin E, Dekovich A, Davila M. Self-expandable metal stents (SEMS) can serve as a bridge to surgery or as a definitive therapy in patients with an advanced stage of cancer: Clinical experience of a tertiary cancer center. Dig Dis Sci 55(12):3530-6, 2010. e-Pub 2010.
203. Kim SM, Park YY, Park ES, Cho JY, Izzo JG, Zhang D, Kim SB, Lee JH, Bhutani MS, Swisher SG, Wu X, Coombes KR, Maru D, Wang KK, Buttar NS, Ajani JA, Lee JS. Prognostic Biomarkers for Esophageal Adenocarcinoma Identified by Analysis of Tumor Transcriptome. PLoS One 5(11), 2010.
204. Ross WA, Egwin CI, Wallace MJ, Wang M, Madoff D, Lee JH. Outcomes in Lymphoma patients with obstructive jaundice: a cancer center experience. Dig Dis and Sci 55(11):3271-7, 2010. e-Pub 2010.
205. Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, Watson TJ, Swisher SG, Members of the MD Anderson Esophageal Cancer Group (Ajani JA, Lee JH, et al.) and the University of Rochester School of Medicine and Dentistry Foregut Group.. Endoscopic Esophageal Tumor Length: A Novel Prognostic Factor for Esophageal Cancer Patients. Cancer 252(4):611-7, 2010. e-Pub 2010.
206. Atiq M, Javle M, Dang S, Lee JH. Cholangiocarcinoma: an endoscopist's perspective. Expert Rev Gastroenterol Hepatol 4(5):601-11, 2010.
207. Swisher SG, Hofstetter W, Komaki R, Correa AM, Erasmus J, Liao Z, Lee JH, Maru D, Mehran R, Patel S, Phan A, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, and Ajani JA. Improved Long-term outcome with chemoradiotherapy strategies in esophageal cancer. Ann Thorac Surg 90(3):892-8, 2010.
208. Kim MP, Correa AM, Lee JH, Rice DC, Roth JA, Mehran RJ, Walsh GL, Ajani JA, Maru DM, Chang JY, Marom EM, Macapinlac HA, Lee JH, Vaporciyan AA, Rice T, Swisher SG, Hofstetter WL. Pathologic T0N1 Esophageal Cancer After Neoadjuvant Therapy and Surgery: An Orphan Status. Ann Thorac Surg 90(3):884-89, 2010.
209. Gu J, Ajani JA, Hawk ET, Ye Y, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Wang KK, Wu X. Genome-wide catalogue of chromosomal aberrations in Barrett's esophagus and esophageal adenocarcinoma: A high-density single nucleotide polymorphism array analysis. Cancer Prev Res (phila PA) 3(9):1176-86, 2010. e-Pub 2010.
210. Murthy SB, Patnana SV, Xiao L, Rohren E, Hofstetter WL, Swisher SG, Liao Z, Lee JH, Bhutani MS, Macapinlac HA, Wang X, Ajani JA. The Standardized uptake value of 18-Fluoro-deoxy-glucose positron emission tomography after chemoradiation and clinical outcome in patients with localized gastroenterology carcinoma. Oncology 78 (5-6):316-322, 2010.
211. Katz MH, Varadhachary GR, Fleming JB, Wolff RA, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, Sun CC, Wang H, Crane CH, Lee JH, Tamm EP, Abbruzzese JL, Evans DB. Serum CA19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation. Ann Surg Oncol 17(7):1794-801, 2010.
212. Das P, Jiang Y, Lee JH, Bhutani MS, Ross WA, Mansfield PF, Ajani JA. Multimodality approaches to localized gastric cancer. J Natl Compr Canc Netw 8(4):417-25, 2010.
213. Ajani JA, Correa AM, Walsh GL, Komaki R, Lee JH, Vaporciyan AA, Rice DC, Yao JC, Maru DM, Hofstetter WL, Phan AT, Swisher SG. Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junction. Cancer 116(7):1656-63, 2010.
214. Weston BA, Iyer RB, Qiao W, Lee JH, Bresalier RS, Ross WA. Ability of Integrated Positron Emission and Computed Tomography to Detect Significant Colonic Pathology: The Experience of a Tertiary Cancer Center. Cancer 116(6):1454-61, 2010.
215. Patnana SV, Murthy SB, Xiao L, Rohren E, Hofstetter WL, Swisher SG, Liao Z, Lee JH, Bhutani MS, Macapinlac HA, Wang X, Ajani JA. Critical role of surgery in patients with gastroesophageal carcinoma with a poor prognosis after chemoradiation as defined by positron emission tomography. Cancer 116(19):4487-94, 2010.
216. Javeri H, Xiao L, Rohren E, Lee JH, Liao Z, Hofstetter W, Maru D, Bhutani MS, Swisher SG, Macapinlac H, Wang X, and Ajani JA. Higher the Decrease in the Standardized Uptake Value of Positron Emission Tomography after Chemoradiation Better the Survival of Patients with Gastroesophageal Adenocarcinoma. Cancer 115(22):5184-92, 2009.
217. Leung KK, Ross WA, Evans D, Fleming J, Lin E, Tamm EP, Lee JH. Pancreatic cystic neoplasm: the role of cyst morphology, cyst fluid analysis, and expectant management. Ann Surg Oncol 16(10):2818-24, 2009. e-Pub 2009. PMID: 19536601.
218. Bhutani MS, Verma D, Guha S, Lee JH, Richards-Kortum RR, Fleming JB. Is Endoscopic Ultrasound "Sound" for Pancreatic Cancer Screening?. J Clin Gastroenterol 43(9):797-802, 2009. PMID: 19652621.
219. Rice DC, Steliga MA, Stewart J, Eapen G, Jimenez C, Lee JH, Hofstetter W, Marom EM, Mehran R, Vaporciyan A, Walsh G, Swisher S. Endobronchial ultrasound guided needle biopsy for staging of malignant pleural mesothelioma. The Annals of Thoracic Surgery 88(3):862-8, 2009.
220. Lee JH, Stewart J, Ross WA, Anandasabapathy S, Xiao L, Staerkel G. Blinded Prospective Comparison of the Performance of 22-gauge and 25-gauge needles in Endoscopic Ultrasound-Guided Fine Needle Aspiration of the Pancreas and Peri-pancreatic lesions. Dig Dis Sci 54(10):2274-81, 2009.
221. Lagaly R, Horak A, Lee JH, Mansfield PF, Ajani JA. Patient with advanced gastric cancer responds twice to the same systemic therapy. Gastrointest Cancer Res 3(3):115-7, 2009.
222. Javeri H, Xiao L, Rohren E, Komaki R, Hofstetter W, Lee JH, Maru D, Bhutani MS, Swisher SG, Wang X, Ajani JA. Influence of the baseline 18F-fluoro-2-deoxy-D-glucose positron emission tomography results on survival and pathologic response in patients with gastroesophageal cancer undergoing chemoradiation. Cancer 115(3):624-630, 2009.
223. Izzo JG, Wu X, Wu TT, Huan P, Lee JS, Liao Z, Lee JH, Bhutani MS, Hofstetter W, Maru D, Hung MC, Ajani JA. Therapy-induced Expression of NF-kB Portends Poor Prognosis in Patients with Localized Esophageal Cancer Undergoing Preoperative Chemoradiation. Dis Esophagus 22(2):127-32, 2009.
224. Cen P, Correa AM, Lee JH, Maru D, Anandasabapathy S, Liao Z, Hofstetter WL, Swisher SG, Komaki R, Ross WA, Vaporciyan A, Ajani JA. Adenocarcinoma of the lower esophagus with Barrett's esophagus or without Barrett's esophagus: differences in patients' survival after preoperative chemoradiation. Dis Esophagus 22(1):32-41, 2009.
225. Ross WA and Lee JH. Endoscopic Approach to Tracheoesophageal Fistulas in Adults. Techniques in Gastrointestinal Endoscopy 10(4):155-163, 2008.
226. Ross WA, Wasan SM, Evans DB, Wolff RA, Trapani LV, Staerkel GA, Prindiville T, Lee JH. Combined endoscopic ultrasound with fine-needle aspiration and endoscopic retrograde cholangiopancreatography in the evaluation of patients presenting with obstructive jaundice from presumed pancreatic malignancy. Gastrointest Endosc 68(3):461-6, 2008.
227. Javeri H, Arora R, Correa AM, Hofstetter WL, Lee JH, Zhongzing L, McAleer MF, Maru D, Bhutani MS, Swisher SG, Izzo JG, Ajani, JA. Influence of Induction Chemotherapy and Class of Cytotoxics on Pathologic Response and Survival After Preoperative Chemoradiation in Patients with Carcinoma of the Esophagus. Cancer 113(6):1302-8, 2008.
228. Katz MH, Mortenson MM, Wang H, Hwang R, Tamm EP, Staerkel G, Lee JH, Evans DB, Fleming JB. Diagnosis and management of cystic neoplasms of the pancreas: an evidence-based approach. J Am Coll Surg 207(1):106-20, 2008.
229. Varadhachary GR, Wolff RA, Crane CH, Sun CC, Tamm EP, Wang H, Lee JE, Pisters PWT, Vauthey JN, Abdalla E, Lee JH, Ho L, Staerkel GA, Bhosale PR, Ross WA, Krishnan S, Xiong H, Das P, Abbruzzese JL, Evans DB. Preoperative Gemcitabine and Cisplatin followed by Gemcitabine-based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head. J Clin Oncol 26(21):3487-95, 2008.
230. Hwang RF, Wang H, Lara A, Gomez H, Chang T, Sieffert N, Moon Y, Ram S, Zimmerman S, Lee JH, Pisters PW, Tamm EP, Fleming JB, Abbruzzese JL, Evans DB. Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer. Ann Surg Oncol 15(5):1356-66, 2008.
231. Cen P, Hofstetter WL, Correa AM, Wu TT, Lee JH, Ross WA, Davila M, Swisher SG, Fukami N, Rashid A, Maru D, Ajani JA. Lymphovascular Invasion as a Tool to Further Subclassify T1b Esophageal Adenocarcinoma. Cancer 112(5):1020-1027, 2008.
232. Ross WA, Ghosh S, Dekovich AA, Liu S, Ayers GD, Cleary KR, Lee JH, Couriel D. Endoscopic biopsy diagnosis of acute gastrointestinal graft-versus-host disease: rectosigmoid biopsies are more sensitive than upper gastrointestinal biopsies. Am J Gastroenterol 103(4):982-9, 2008.
233. Weston BR, Ross WA, Wolff RA, Evans D, Lee JE, Wang X, Xiao LC, Lee JH. Rate of bilirubin regression after stenting in malignant biliary obstruction for the initiation of chemotherapy: How soon should we repeat endoscopic retrograde cholangiopancreatography?. Cancer 112(11):2417-23, 2008. PMID: 18404695.
234. Tamm EP, Bhosale PR, Lee JH. Pancreatic Ductal Adenocarcinoma: Ultrasound, Computed Tomography, and Magnetic Resonance Imaging Features. Seminars in Ultrasound CT and MRI 28(5):330-338, 2007.
235. Patel PR, Mansfield PF, Crane CH, Wu TT, Lee JH, Lynch PM, Morris J, Pisters PW, Feig B, Sunder PK, Izzo JG, Ajani JA. Clinical stage after preoperative chemoradiation is a better predictor of patient outcome than the baseline stage for localized gastric cancer. Cancer 110(5):989-95, 2007.
236. Izzo JG, Luthra R, Sims-Mourtada J, Chao KS, Lee JH, Wu TT, Correa AM, Luthra M, Aggarwal B, Hung MC, Ajani JA. Emerging molecular targets in esophageal cancers. Gastrointest Cancer Res 1(4 (suppl 2)):S3-6, 2007.
237. Northrop JA, Lee JH. Large bowel carcinoid tumors. Curr Opin Gastroenterol 23(1):74-8, 2007. PMID: 17133089.
238. Ross WA, Alkassab F, Lynch PM, Ayers GD, Ajani J, Lee JH, Bismar M. Evolving role of self-expanding metal stents in the treatment of malignant dysphagia and fistulas. Gastrointest Endosc 65(1):70-6, 2007. PMID: 17185082.
239. Cen P, Hofstetter WL, Lee JH, Ross WA, Wu TT, Swisher SG, Davila M, Rashid A, Correa AM, Ajani JA. Value of Endoscopic Ultrasound Staging in Conjunction with the Evaluation of Lymphovascular Invasion in Identifying Low-Risk Esophageal Carcinoma. Cancer 112(3):503-10, 2007. e-Pub 2007.
240. Erasmus JJ, Munden RF, Truong MT, Ho JJ, Hofstetter WL, Macapinlac HA, Correa AM, Wu TT, Bruzzi JF, Marom EM, Sabloff BS, Ajani JA, Komaki R, Liao Z, Lee JH, Fukami N, Bresalier R, Swisher SG. Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imaging. J Thoracic Oncol 1(5):478-486, 2006.
241. Raut CP, Cleary KR, Staerkel GA, Abbruzzese JL, Wolff RA, Lee JH, Vauthey JN, Lee JE, Pisters PW, Evans DB. Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival. Ann Surg Oncol 13(4):582-94, 2006. PMID: 16523362.
242. Izzo JG, Malhotra U, Wu TT, Ensor J, Luthra R, Lee JH, Swisher SG, Liao Z, Chao KS, Hittelman WN, Aggarwal BB, Ajani JA. Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinoma. J Clin Oncol 24(5):748-54, 2006. PMID: 16401681.
243. Fukami N, Lee JH. Endoscopic treatment of large sessile and flat colorectal lesions. Curr Opin Gastroenterol 22(1):54-9, 2006. PMID: 16319677.
244. Luthra R, Wu TT, Luthra MG, Izzo J, Lopez-Alvarez E, Zhang L, Bailey J, Lee JH, Bresalier R, Rashid A, Swisher SG, Ajani JA. Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation. J Clin Oncol 24(2):259-67, 2006. PMID: 16344314.
245. Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Lahoti S, Lee JH, Bresalier R, Roth JA, Swisher SG. Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinoma. J Thorac Cardiovasc Surg 131(1):65-72, 2006. PMID: 16399296.
246. Al-Refaie WB, Choi EA, Tseng JF, Tamm EP, Lee JH, Lee JE, Evans DB, Pisters PW. Intraductal papillary mucinous neoplasms of the pancreas. Med Princ Pract 15(4):245-52, 2006. PMID: 16763389.
247. Rohatgi PR, Correa AM, Swisher SG, Wu TT, Liao Z, Komaki R, Walsh GL, Vaporciyan AA, Lee JH, Rice DC, Roth JA, Ajani JA. Gender-based analysis of esophageal cancer patients undergoing preoperative chemoradiation: differences in presentation and therapy outcome. Dis Esophagus 19(3):152-7, 2006. PMID: 16722991.
248. Lee JH. Interventional gastroenterology: esophageal and pancreatic cancers. Semin Oncol 32(6 Suppl 8):25-8, 2005. PMID: 16360009.
249. Mullen JT, Wang H, Yao JC, Lee JH, Perrier ND, Pisters PW, Lee JE, Evans DB. Carcinoid tumors of the duodenum. Surgery 138(6):971-7; discussion 977-8, 2005. PMID: 16360380.
250. Mullen JT, Lee JH, Gomez HF, Ross WA, Fukami N, Wolff RA, Abdalla EK, Vauthey JN, Lee JE, Pisters PW, Evans DB. Pancreaticoduodenectomy after placement of endobiliary metal stents. J Gastrointest Surg 9(8):1094-104; discussion 1104-5, 2005. PMID: 16269380.
251. Hong D, Lunagomez S, Kim EE, Lee JH, Bresalier RS, Swisher SG, Wu TT, Morris J, Liao Z, Komaki R, Ajani JA. Value of baseline positron emission tomography for predicting overall survival in patients with nonmetastatic esophageal or gastroesophageal junction carcinoma. Cancer 104(8):1620-6, 2005. PMID: 16118804.
252. Wasan SM, Ross WA, Staerkel GA, Lee JH. Use of expandable metallic biliary stents in resectable pancreatic cancer. Am J Gastroenterol 100(9):2056-61, 2005. PMID: 16128952.
253. Sheehan S, Lee JH, Wells CK, Topazian M. Serum Amylase, Pancreatic Stents, and Pancreatitis After Sphincter of Oddi Manometry. Gastrointest Endosc 62(2):260-265, 2005.
254. Aslanian H, Salem R, Lee JH, Andersen D, Robert M, Topazian M. EUS diagnosis of vascular invasion in pancreatic cancer: surgical and histologic correlates. Am J Gastroenterol 100(6):1381-1385, 2005.
255. Aslanian H, Salem R, Lee JH, Robert M, Topazian M. EUS guided ethanol injection of normal porcine pancreas: A pilot study. Gastrointest Endosc 62(5):723-727, 2005.
256. Aspelund G, Topazian MD, Lee JH, Andersen DK. Improved outcomes with limited pancreatic head resections for benign disease. J Gastrointest Surg 9(3):400-409, 2005.
257. Prasad P, Salem RR, Mangla R, Aslanian H, Jain D, Lee JH. Lymphoplasmacytic Sclerosing Pancreatitis: A Case Report. Yale J Biol Med 77:143-148, 2005.
258. Evans DB, Lee JH, Crane CH. Authors response regarding letter to the editor from JP Hoffman concerning: Mullen JT, Lee JH, Gomez HF, Ross WA, Fukami N, Wolff RA, Abdalla EK, Vauthey J-N, Lee JE, Pisters PWT, Evans DB. J Gastrointest Surg 9(8):1104-1105, 2005.
259. Hong-Curtis J, Yeh MM, Jain D, Lee JH. Rapid progression of autoimmune hepatitis in the background of primary sclerosing cholangitis. J Clin Gastroenterol 38(10):906-909, 2004.
260. Lee JH, Salem R, Aslanian H, Chacho M, Topazian M. Endoscopic ultrasound and fine-needle aspiration of unexplained bile duct strictures. Am J Gastroenterol 99(6):1069-1073, 2004.
261. Lee JH, Topazian M. Pancreatic endosonography after Billroth II gastrectomy. Endoscopy 36(11):972-975, 2004.
262. Lee JH. Longitudinal Endosonograpy. J Clin Gastroenterol 34(2):196, 2002.
263. Jacobson BC, Hirshch MS, Lee JH, Van Darn J, Shoji B, Farraye F. Multiple asymptomatic plexiforrn schwannomas of the sigmoid colon: a case report and review. Gastrointest Endosc 53(7):801-804, 2001. PMID: 11375596.
264. Yim HB, Jacobson BC, Saltzman JR, Johannes RS, Bounds BC, Lee JH, Shields SJ, Ruymann FW, Van Dam J, Carr-Locke DL. Clinical outcome of the use of enteral stents for palliation of patients with malignant upper GI obstruction. Gastrointest Endosc 53(3):329-32, 2001.
265. Ajani, JA, Izzo J, Wang X, Chao C, Wu, TT, Malhotra, U, Vaporciyan AA, Lee JH, Bhutani M, Liao Z, Lee, JS, Wu, X, Berry D. Biomarker Signature that is highly predictive of pathologic complete response in patients with gastroesophageal adenocarcinoma undergoing preoperative chemoradiation. Journ of Clin Onc. PMID: 22831985.
266. Raju, GS, Lum P, Ross W, Thirumurthi S, Miller E, Lynch P, Lee JH, Bhutani M, Shafi MA, Weston B, Blechacz B, Chang GJ, Hagan K, Rashid A, Davila M, Stroehlein J. Opportunities for improvement of the quality of care for patients with large colon polyps. DDW 2023.
267. Low D, Nehme F, Coronel M, Nakshabandi A, Lee J, Ge PS, Coronel E, Ross WA, Weston BR. Outcomes of inpatients with large volume hepatic tumor burden declined for ercp in a tertiary referral cancer center. DDW 2023.

Invited Articles

1. Lee JH, Neuduck B. The Continuum of Patient Care Related to Acid Suppression. Pharmacy Practice News, Gastroenterology and Endoscopy News, 2003.
2. Lee JH. Endoscopic Management of Gastroesophageal Reflux Disease. American College of Gastroenterology 2003 Highlights, 2003.

Manuals, Teaching Aids, Other Teaching Publications

1. Lee JH. CME-What Tools do we use to establish a diagnosis of autoimmune pancreatitis. Gastrointest Endosc, 2012.
2. Lee JH. CME-Where are we with high-resolution imaging technology?. Gastrointest Endosc, 2012.
3. Lee JH. CME-Utility of SEMS in neoadjuvant therapy in pancreatic cancer. Gastrointest Endosc, 2012.
4. Lee JH. CME-Is there any difference in endoscopic appearance between proximal and distal colorectal neoplasms?. Gastrointest Endosc, 2012.
5. Lee JH. CME-GI bleeding after LVAD implantation. Gastrointest Endosc, 2012.
6. Lee JH. CME-The value of CWP and aspiration during EUS-FNA. Gastrointest Endosc, 2012.
7. Lee JH. CME-What would be the most accurate surveillance technique for post-EMR scar evaluation?. Gastrointest Endosc, 2012.
8. Lee JH. CME-Are standard biopsies sufficient for post-ablation surveillance for Barrett's esophagus?. Gastrointest Endosc, 2012.
9. Lee JH. CME-Is EUS-guided rendezvous more efficient than precut papillotomy technique for biliary access?. Gastrointest Endosc, 2012.
10. Lee JH. CME-What are the predictors of adverse events for EUS-guided biliary drainage with transluminal stenting in biliary stricture. Gastrointest Endosc, 2011.
11. Lee JH. Post graduate course syllabus. Endoscopic management of malignant biliary and pancreatic strictures. American College of Gastroenterology Annual Meeting, 2011.
12. Lee JH. CME-What are the strengths of various image-enhancing technologies in EUS?. Gastrointest Endosc, 2011.
13. Lee JH. CME-Is there a difference between covered versus uncovered metal stents for palliation of bile duct obstruction?. Gastrointest Endosc, 2011.
14. Lee JH. CME-Screening tools for pancreatic cancer in high risk individuals. Gastrointest Endosc, 2011.
15. Lee JH. CME-Quality of EUS in assessing gastric cancer. Gastrointest Endosc, 2011.
16. Lee JH. CME-Is endoscopic assessment good enough to establish T-staging for EGC?. Gastrointest Endosc, 2011.
17. Lee JH. CME-Diagnostic tools for pancreatic neuroendocrine tumors. Gastrointest Endosc, 2011.
18. Raju GS, Atiq M, Lee JH. EUS Learning Series: Gastric Cancer EUS Staging. DAVE PROJECT, 2011.
19. Raju GS, Jaganmohan S, Lee JH. EUS Learning Series: Linitis Plastica. DAVE Project, 2011.
20. Lee JH. CME-A quick measure of the quality of colonoscopy. Gastrointest Endosc, 2011.
21. Lee JH. CME-Complications of EUS-guided FNA. Gastrointest Endosc, 2011.
22. Lee JH. CME-Is EUS-FNA accurate in the evaluation of suspected cholangiocarcinoma?. Gastrointest Endosc, 2011.
23. Lee JH. CME-How to drain hilar obstruction. Gastrointest Endosc, 2010.
24. Lee JH. CME-What should be the initial diagnostic test(s) for a patient with upper abdominal pain. Gastrointest Endosc, 2010.
25. Lee, JH. CME-Risk factors for post-ERCP pancreatitis in a patient with pancreatic cancer. Gastroinest Endosc, 2010.
26. Lee JH. CME-What is the most effective and least invasive treatment for postoperative biliary stricture. Gastrointest Endosc, 2010.
27. Lee JH. What are the endosonographic features predictive of malignancy on FNA in lung cancer-associated mediastinal lymph nodes?. Gastrointest Endosc, 2010.
28. Lee JH. CME-How can we minimize radiation to ERCP patients?. Gastrointest Endosc, 2010.
29. Lee JH. CME-How can you improve the yield of EUS-FNA results?. Gastrointest Endosc, 2010.
30. Lee, JH. CME-How can you improve the yield of EUS-FNA results? How good is optical coherence tomography in the staging cancer?. Gastrointest Endosc, 2010.
31. Lee, JH. CME-How good is endoscopic management of nonampullary duodenal polyps?. Gastrointest Endosc, 2010.
32. Lee JH. CME-What is the outcome of endoscopic insertion of SEMS for malignant colonic obstruction?. Gastrointest Endosc, 2010.
33. Lee, JH. CME-What are the risk factors for post-ERCP pancreatitis?. Gastrointest Endosc, 2010.
34. Lee JH. CME-Significance of Jackson Pratt fluid to serum bilirubin concentration ratio for the diagnosis of bile leaks. Gastrointest Endosc, 2010.
35. Lee JH. CME-Outcome of ampullectomy. Gastrointest Endosc, 2009.
36. Lee JH. CME-Is alcohol a friend of the pancreas? What are the predictors of ERCP complications?. Gastrointest Endosc, 2009.
37. Lee JH. CME-Dosing of proton pump inhibitors in peptic ulcer bleeding patients. Gastrointest Endosc, 2009.
38. Lee JH. CME-What are the benefits of using carbon dioxide (O2) during ERCP?. Gastrointest Endosc, 2009.
39. Lee JH. CME-What are predictors of ERCP complications. Gastrointest Endosc, 2009.
40. Lee JH. Diagnosis and Staging of Pancreatic Cancer by EUS. Course Syllabus, Endoscopic and Comprehensive Management of Esophageal and pancreatic Malignancy, 2007.
41. Lee JH. Pancreatic Cancer: Issues of Metal Stents. Course Syllabus, Endoscopic and Comprehensive Management of Esophageal and Pancreatic Malignancy, 2007.
42. Lee JH. Pancreaticobiliary Endoscopy. Course Syllabus, The Best of DDW, 2005.
43. Lee JH. Endoscopic Ultrasound and Imaging. Course Syllabus, The Best of DDW, 2005.
44. Lee JH. Endoscopic Retrograde Cholangiopancreatography, Endoscopic Ultrasonography, and Fine Needle Aspiration for Staging and Diagnosis of Pancreatic Cancer. Course Syllabus, 2nd Multidisciplinary Management of Gastrointestinal Malignancies, 2004.
45. Lee JH. Endoscopic Management of Biliary Obstruction, Course Syllabus. GHSGNA Annual Fall Course, 2004.
46. Lee JH. How To Use Sengstaken-Blakemore Tube. Yale-New Haven Hospital, 2002.
47. Lee, JH. CME-Cholangiopancreatoscopy: why and for whom?. Gastrointest Endosc, 2000.

Editorials

1. Singh A, Lee JH. self-expanding metal stents for preoperative biliary drainage in patients receiving neoadjuvant therapy for pancreatic cancer. J Gastrointest Oncol 3(4):304-5, 2012.
2. Lee JH. Is combination biliary sphincterotomy and balloon dilation a better option than either alone in endoscopic removal of large bile-duct stones?. Gastrointest Endosc 66(4):727-729, 2007.

Abstracts

1. Ali FS, Nehme F, Nogueras-González, GM, Low D, Nakshabandim A, Lum P, Ge PS, Ross, WA, Coronel E, Lee JH; Weston BR. Esophageal stent fixation and migration risk of fully covered self-expanding metal stents: a tertiary cancer center experience. DDW 2023 59(11):2035, 2023. e-Pub 2023. PMID: 38004084.
2. Nakshabandi AA, Ali F, Al-Bustami IS, Johnston N, Shaikh A, Low DJ, Ross WA, Weston BR, Ge P, Coronel E, Lee JH. Biliary drainage in perihilar cholangiocarcinoma – 25 year experience at a large US tertiary cancer center, 2023.
3. Low DJ, Al-Bustami IS, Weston BR, Ge P, Coronel E, Ross WA, Nakshabandi AA, Hame PS, Lee JH. The use of lumen apposing metal stent in non-peripancreatic fluid collections at a tertiary care oncology center between 2017 and 2022, 2023.
4. Low DJ, Al-Bustami IS, Ross WA, Weston BR, Coronel E, Nakshabandi AA, Ge P, Lee JH. Analysis of pancreatic cystic lesions and factors assoiciated with pancreas adenocarcinoma development from 2000-2023 at a tertiary care oncology center, 2023.
5. Lee JH, Johnston N, Al-Bustami IS, Low DJ, Ross WA, Coronel E, Ge P, Weston BR.. The outcomes of ampullary adenomas in observation without intervention, endoscopic papillectomy, and surgical intervention, 2023.
6. Low DJ, Nakshabandi A, Liu C, Ali FS, Ge PS, Coronel E, Weston Br, Ross WA, Lee J. Analysis of technical failure in post-pancreaticoduodenectomy patients undergoing endoscopic retrograde cholangiopancreatography. DDW 2023 97(6), 2023. e-Pub 2023.
7. Low DJ, Nakshabandi A, Ali FS, Liu C, Ge PS, Coronel E, Weston BR, Ross WA, Lee J. Endoscopic retrograde cholangiopancreatography in patients with pancreaticoduodenectomy with and without rigidizing overtube. DDW 2023 6(1):66, 2023. e-Pub 2023.
8. Low D, Nakshabandi A, Liu, Cynthia, Ali FS, Lee J, G PS, Weston BR, Coronel E. Complex endoscopic retrograde cholangiopancreatography in patients with pancreaticoduodenectomy using rigidizing overtube. DDW 2023, 2023. e-Pub 2023.
9. Zhao M, Prakash RL, Hill VF, Chiang YJ, Lee JH, Ross WA, Coronel E, Ge P, Weston B, Maxwell JE, Newhook TE, Tzeng, Ikoma N, Lee JE, Katz MHG, Bhutani MS, Kim MP. Cyst Fluid Glucose Levels are Superior to Cyst Fluid CEA levels in the Identification of Mucinous Pancreatic Cysts. SSAT/DDW 2022, 2022.
10. Nehme F, Lee JH. Diagnostic accuracy and utility of eus-fna for incidental subcentimeter pancreatic solid lesions. ASGE/DDW 2022, 2022.
11. Nehme F, Lee JH. The use of a flexible rigidizing overtube for endoscopic retrograde cholangiopancreatography in post pancreaticoduodenectomy. ASGE/DDW 2022, 2022.
12. Nehme F, Lee JH. Predictors of malignancy for patients with inconclusive endoscopic ultrasound-guided fine needle aspiration of solid pancreatic masses. ASGE/DDW 2022, 2022.
13. Nehme F, Lee JH. Impact of inconclusive endoscopic ultrasound-guided fine-needle aspiration on the management and outcomes of patients with solid pancreatic masses at a tertiary referral center. ASGE/DDW 2022, 2022.
14. Nehme F, Ge P, Coronel E, Weston B, Ross W, Yu A, Liu C, Lum P, Ali F, Lee J. Endoscopic ultrasound evaluation of primary pancreatic lymphoma compared to adenocarcinoma: a case-control study. ASGE/DDW 2022, 2022.
15. Nehme F, Lee JH. Combination testing of intracystic glucose and cea improves diagnostic accuracy of pancreatic cystic lesions. ASGE/DDW 2022, 2022.
16. Nehme F, Lee JH. The combination of cyst fluid glucose and string sign increases the diagnostic accuracy of mucinous pancreatic cysts. ASGE/DDW 2022, 2022.
17. Nehme F, Lee JH. Efficacy of anchoring fully covered esophageal metal stents to prevent migration: a case-control study. ASGE/DDW 2022, 2022.
18. Nehme F, Lee JH. Factors associated with migration of fully-covered esophageal metal stents. ASGE/DDW 2022, 2022.
19. Nehme F, Yu A, Ali F, Liu C, Coronel E, Weston B, Ross W, Ge P, Lum P, Low D, Lee JH. Differential diagnosis and management of subcentimeter solid pancreatic lesions. ASGE/DDW 2022, 2022.
20. Ali F, Lee JH. Palliation of malignant hilar biliary obstruction with bilateral plastic or metal stent placement - a cost effectiveness analysis. ASGE/DDW 2022, 2022.
21. Ali F, Lee JH. Bilateral plastic stent versus self expanding metal stent deployment for palliation of malignant hilar biliary obstruction - a meta-analytic evidence profile. ASGE/DDW 2022, 2022.
22. Ali F, Lee JH. Endoscopic submucosal dissection of esophagastric junction lesions- a pooled analysis and comparative meta-analysis of Barrett's adenocarcinoma and gastric adenocarcinoma. ASGE/DDW 2022, 2022.
23. Coronel M, Lee JH. Outcomes of duodenal stent placement for malignant gastric outlet obstruction. Experience for a large tertiary care center. ACG 2021, 2021.
24. Yu A, Kumar S, Coronel M, Coronel E, Ge PS, Bhutani MS, Weston BR, Ross WA, Lee, JH. Acute pancreatitis after endoscopic ultrasound guided sampling of pancreatic lesions. DDW 2021, 2021.
25. Yu A, Emelogu IK, Coronel M, Coronel E, Ge PS, Weston BR, Bhutani MS, Ross WA, Kumar S, Lee JH. Long-term surveillance of pancreatic cysts can detect cancer early, but better predictors are needed. DDW 2021, 2021.
26. Bahdi F, Yu A, Emelogu IK, Coronel M, Ge PS, Coronel E, Weston BR, Lynch PM, Ross WA, Kumar S, Lee JH. Esophageal stent placement for management of malignant dysphagia. DDW 2021, 2021.
27. Emelogu IK, Bahdi F, Yu A, Coronel M, Coronel E, Ge PS, Weston BR, Ross, WA, Lynch PM, Kumar, S, Lee JH. Migration of esophageal stents placed for malignant obstruction. DDW 2021, 2021.
28. Kumar S, Bahdi F, Yu A; Emelogu IK, Coronel M, Coronel E, Ge PS, Weston BR, Lynch PM, Lee JH. Trends in the performance and use of esophageal stents for malignant dysphagia over time. DDW 2021, 2021.
29. Emelogu IK, Kumar S, Yu A, Coronel M, Coronel E, Ge PS, Weston BR, Ross WA, Lee JH. Metal biliary stents for biliary obstruction in cholangiocarcinoma. DDW 2021, 2021.
30. Kumar S, Coronel E, Coronel M, Ge PS, Bhutani MS, Weston BR, Ross WA, Lee JH. Endoscopic submucosal dissection of lesions with an underlying or adjacent varix – a systematic review of the literature. DDW 2021, 2021.
31. Lee JH. Endoscopic submucosal dissection in patients with liver cirrhosis – a meta-analytic efficacy and adverse effect profile. DDW 2021, 2021.
32. Coronel M, Kumar D, Bahdi F, Kumar S, Lum P, Nogueras G, Weston B, Ross WA, Raju GS, Ge PS, Coronel E , Lee JH. The use of ERCP in the diagnosis of indeterminate biliary strictures. Experience from a large tertiary care center. DDW 2021, 2021.
33. Coronel M, Yu A, Kumar S, Ge PS, Nogueras G, Lum P, Weston B, Ross WA, Raju GS, Coronel E, Lee JH. Clinical outcomes of gastric and duodenal neuroendocrine tumors. Experience from a large tertiary care cancer center. DDW 2021, 2021.
34. Coronel M, Ge PS, Kumar S, Lum P, Weston B, Ross WA, Raju GS, Lee JH, Coronel E. Efficacy and safety of endoscopic fixation to prevent migration of esophageal stents. A tertiary care center experience. DDW 2021, 2021.
35. Kumar S; Coronel E; Coronel M; Ge PS; Bhutani MS; Weston BR; Ross WA; Leeb JH. Endoscopic ultrasound characteristics of pancreatic neuroendocrine tumors. DDW 2021, 2021.
36. Coronel M, Bahdi F, Kumar D, Kumar S, Lum P, Nogueras G, Weston B, Ross WA, Raju GS, Ge PS, Coronel E, Lee JH. The use of EUS and ERCP in the diagnosis of extrahepatic biliary cholangiocarcinoma. Experience from a large tertiary care center. DDW 2021, 2021.
37. Lee JH. Clinical Utility of Endoscopic Ultrasound-Guided Deployment Of Lumen-Apposing Metal Stents For Malignant Afferent Limb Syndrome; A Descriptive Analysis. DDW 2020, 2020.
38. Lee JH. Endoscopic ultrasound-guided gastroenterostomy for the treatment of gastric outlet obstruction; a meta-analysis of direct and balloon-assisted approach. DDW 2020, 2020.
39. Lee JH. Endoscopic insertion of enteral self-expanding metal stents for gastric outlet or afferent limb obstruction in patients with a surgically altered anatomy; a meta-analysis. DDW 2020, 2020.
40. Lee JH. Endoscopic ultrasound (EUS) with fine needle aspiration (FNA) for the evaluation of pancreatic metastases and lymphoma. DDW 2020, 2020.
41. Lee JH. Efficacy, safety; and procedure characteristics of endoscopic ultrasound (EUS) with fine needle aspiration (FNA) for the diagnosis of suspected pancreatic adenocarcinoma. DDW 2020, 2020.
42. Lee JH. Evaluating the safety and efficacy of endoscopic ultrasound (EUS) with fine needle aspiration (FNA) for the diagnosis of cystic pancreatic lesions. DDW 2020, 2020.
43. Lee JH. Evaluating endoscopic ultrasound (EUS) with fine needle aspiration (FNA) for the diagnosis of pancreatic neuroendocrine tumors; a ten-year, retrospective analysis. DDW 2020, 2020.
44. Lee JH. Evaluating the impact of attending physician career phase on endoscopic ultrasound (EUS) with fine needle aspiration (FNA) safety and efficiency. DDW 2020, 2020.
45. Lee JH. Evaluating the impact of advanced endoscopy fellow involvement on endoscopic ultrasound (EUS) with fine needle aspiration (FNA) and endoscopic retrograde cholangio­pancreatography (ERCP). DDW 2020, 2020.
46. Low DJ, Nakshabandi A, Coronel E, Ge PS, Weston BR, Ross WA, Lee J. Percutaneous transhepatic biliary drainage after failed endoscopic retrograde pancreatography in unresectable perihilar cholangiocarcinoma. DDW 2023 8(2):E203–E210, 2020. e-Pub 2020. PMID: 32010755.
47. Lee JH. Management of Ampullary Lesions: 16 Years of experience from a tertiary cancer center. DDW 2019, 2019.
48. Lee JH. EUS-guided biliary drainage after failed ERCP: A tertiary Cancer Center Experience. DDW 2019, 2019.
49. Lee JH. Peroral Single-operator cholangioscopy for diagnosis and management of Malignant Strictures: A Tertiary Cancer Care Center Experience. DDW 2019, 2019.
50. Lee JH. Esophageal Stent Placement for Post-operative Complications in Patients with Esophageal surgery secondary to malignancy. DDW 2019, 2019.
51. Lee JH. Utility of Endoscopic Ultrasound in the Diagnosis of Cholangiocarcinoma. DDW 2019, 2019.
52. Lee JH. Outcomes of Endoscoopic Resection of non-ampullary duodenal adenomas: A tertiary Cancer Center Experience. DDW 2019, 2019.
53. Lee JH. Endoscopic Management of Duodenal Nueroendocrine tumors. DDW 2019, 2019.
54. Lee JH. Role of Argon Plasma coagulation in the setting of endoscopic retrograde cholangiopancreatography. DDW 2019, 2019.
55. Lee JH. Characteristics and Endoscopic Management of Gastric neuroendocrine tumors. DDW 2019, 2019.
56. Lee JH. Characteristics of Gastrointestinal Stromal tumors using endoscopic ultrasound. DDW 2019, 2019.
57. Lee JH. Efficacy of Lumen-apposing metal stent insertion in patients with malignant pancreatic fluid collections: A tertiary Cancer Center Experience. DDW 2019, 2019.
58. Lee JH. Endoscopic radio frequency ablation in the management of unresectable hilar and distal cholangiocarcinoma: A Systemic review and meta-analysis. DDW 2019, 2019.
59. Lee JH. Comparison of the performance of covered metal stents and uncovered metal stents in the management of malignant biliary strictures (MBO) in 1012 patients. DDW 2018, 2018.
60. Lee JH, Emelogu IK, Coronel E, Nogueras-Gonzalez GM, Lum P, Ross WA, Raju GS, Lynch PM, Thirumurthi S, Stroehlein JR, Wang Y, You YN, Weston BR. Are SEMS (self-expanding metal stents) a safe and successful bridge to surgery or definitive therapy for malignant colorectal obstruction (MCO), particularly in patients treated with bevacizumab, a VEGF inhibitor? A tertiary cancer center experience. DDW 2018, 2018.
61. Lee JH. The characteristics, pathologic predictors of recurrence, and utility of surgical resection of solid pseudopapillary neoplasms: a 20 year experience at a tertiary cancer center. DDW 2018, 2018.
62. Lee JH. Diagnostic value of EUS-FNA for metastatic lesions to the pancreas. A 10-year tertiary care center experience. DDW 2018, 2018.
63. Lee JH. Characterization and predictors of disease progression in pancreatic neuroendocrine tumors diagnosed by EUS-FNA. A 10-year tertiary care center experience. DDW 2018, 2018.
64. Lee JH. Long-term outcomes in patients who underwent surgery after EUS-FNA diagnosis of neoplastic solid pancreatic lesions (NSPL). A 5-year tertiary care center experience. DDW 2018, 2018.
65. Lee JH. Clinical utility of the 2017 Fukuoka consensus and 2015 American Gastroenterological Association guidelines in the management of intraductal papillary mucinous neoplasms (IPMNS). DDW 2018, 2018.
66. Lee JH. Non-invasive imaging modalities as an adjunct to EUS-FNA with on-site cytology evaluation for neoplastic solid pancreatic lesions. A tertiary care center experience. DDW 2018, 2018.
67. Lee JH. Endoscopic ultrasound guided needle aspiration with immediate on-site cytology evaluation and outcomes for pancreatic adenocarcinoma. A 5-year tertiary care center experience. DDW 2018, 2018.
68. Lee JH. Endoscopic management and outcomes of ampullary lesions. A 5-year tertiary care center experience. DDW 2018, 2018.
69. Lee JH. The single session: feasibility and outcomes of combined EUS-FNA and ERCP procedures. A 5-year tertiary care center experience. DDW 2018, 2018.
70. Petersen B, Arain M, Baron T, Lee J, Branch S, Draganov P, Al-Kaade S, Mullady D, Bennette R, Hemerick J, Ross D, Dassner S, Aaron Foss, Pearlman A, Saunders J, Rivera-Bermudez M, Scutti J, Clerc C, Swanson L, Amos D, Favreau J. Assessment of the effects of paclitaxel eluting SEMS on naive porcine biliary tissue. Prometheus UEGW, 2018.
71. Gulhati P, Prakash L, Katz MH, Wang X, Javle MM, Shroff RT, Fogelman DR, Lee JE, Tzeng CD, H Lee JH, Weston B, Tamm EP, Bhosale P, Koay EJ, Maitra A, Wang H, Wolff RA, Varadhachary GR. First line gemcitabine and nab-paclitaxel chemotherapy for localized pancreatic ductal adenocarcinoma. ASCO 2018, 2018.
72. Harada K, Wu CC, Wang X, Kaya DM, Amlashi FG, Lin Q, Blum MA, Maru DM, Weston B, Lee JH, Bhutani MS, Hofstetter WL, Nguyen Q, Ajani JA. Metabolic activity to predict clinical response and prognosis in esophageal adenocarcinoma patients treated with bimodality. ASCO 2018, 2018.
73. Kaya DM, Nogueras-Gonzalez GM, Estrella J, Harada K, Amlashi FG, Lin Q, Blum Murphy MA, Lee JH, an Weston BR, Bhutani MS, Matamoros Jr. A, Sagebiel TL, Devine CE, Patnana M, Minsky BD, Das P, Badgwell BD, Ajani JA. Potentially curable gastric adenocarcinoma (GAC) patients treated without surgery. ASCO 2018, 2018.
74. Coronel E, Kukreja K, Glover M, Ali F, Nogueras-Gonzalez G, Lum P, Ross W, Weston B, Bhutani M, Lee JE, Katz M, Lee JH. Endoscopic ultrasound guided needle aspiration with immediate on-site cytology evaluation and outcomes for pancreatic adenocarcinoma. A 5-year tertiary care center experience. DDW 2018, 2018.
75. Coronel E, Glover M, Kukreja K, Ali F, Gonzalez GN, Lanke G, Lum P, Ross W, Weston B, Lee JE, Bhutani M, Lee JH. Characterization and predictors of disease progression in pancreatic neuroendocrine tumors diagnosed by EUS-FNA. A 10-year tertiary care center experience. DDW 2018, 2018.
76. Coronel E, Kukreja K, Glover M, Ali F, Nogueras-Gonzalez G, Lum P, Ross W, Weston B, Bhutani M, Lee JH. Diagnostic value of EUS-FNA for metastatic lesions to the pancreas. A 10-year tertiary care center experience. DDW 2018, 2018.
77. Kukreja K, Coronel E, Glover M, Ali F, Nogueras-Gonzalez G, Lum P, Ross W, Weston B, Bhutani M, Lee JH. The diagnostic value of EUS-FNA and outcomes in patients with rare pancreatic malignancies. A 10-year tertiary care center experience. DDW 2018, 2018.
78. Glover M, Coronel E, Kukreja K, Ali F, Nogueras-Gonzalez G, Lum P, Ross W, Weston B, Bhutani M, Lee JH. Non-invasive imaging modalities as an adjunct to eus-fna with on-site cytology evaluation for neoplastic solid pancreatic lesions. A tertiary care center experience. DDW 2018, 2018.
79. Coronel E, Glover M, Kukreja K, Nogueras-Gonzalez G, Lum P, Arnold B, Ali F, Ross W, Raju GS, Weston B, Bhutani M, Lanke G, Katz M, Lee JE, Lee JH. The single session: feasibility and outcomes of combined EUS-FNA and ERCP procedures. A 5-year tertiary care center experience. DDW 2018, 2018.
80. Coronel E, Glover M, Kukreja K, Nogueras-Gonzalez G, Lum P, Ali F, Ross W, Weston B, Bhutani M, Lee JE, Katz M, Lee JH. Long-term outcomes in patients who underwent surgery after eus-fna diagnosis of neoplastic solid pancreatic lesions (nspl). A 5-year tertiary care center experience. DDW 2018, 2018.
81. Coronel E, Patel J, Ross W, Nogueras-Gonzalez G, Weston B, Katz M, Lee JE, Lynch P, Lee JH. Endoscopic management and outcomes of ampullary lesions. A 5-year tertiary care center experience. DDW 2018, 2018.
82. Coronel E, Lanke G, Nogueras-Gonzalez G, Ross W, Weston B, Bhutani M, Katz M, Kim M, Lee JH. Clinical utility of the 2017 Fukuoka consensus and 2015 American Gastroenterological Association guidelines in the management of intraductal papillary mucinous neoplasms (ipmns). DDW 2018, 2018.
83. Coronel E, Lee J, Ross W, Davila M, Bhutani M, Raju GS, Lynch P, Weston B. Efficacy of self expandable metal stents in extrinsic malignant colonic obstruction. A 10-year tertiary care center experience. DDW 2018, 2018.
84. Coronel E, Abu-sbeih H, Gonzales Nogueras G ,Sutaria A, Kim M, Weston B, Lum P, Ross W, Katz M, Lee JE, Lee JH, Bhutani MS. Long-term outcomes of mucinous pancreatic cystic lesions in cancer survivors or patients with extra-pancreatic malignancy. DDW 2018, 2018.
85. Abu-Sbeih H, Coronel E, Lum P, Shuttlesworth G, Lee J, Wang Y. The yield of endoscopic evaluation in the management of gastrointestinal bleeding in cancer patients with thrombocytopenia. DDW 2018, 2018.
86. Abu-Sbeih H, Coronel E, Chen HC, Wang X, Bhutani M, Lee JH, Raju GS, Ross W, Stroehlein J, Lum P, Shuttlesworth G, Wang Y. Safety of endoscopic procedures in cancer patients with neutropenia: five years cancer center experience. DDW 2018, 2018.
87. Abu-Sbeih H, Coronel E, Chen HC, Wang X, Bhutani M, Lee J, Raju GS, Ross W, Stroehlein J, Lum P, Shuttlesworth G, Wang Y. Safety of endoscopic procedures in cancer patients with thrombocytopenia: a tertiary care cancer center experience. DDW 2018, 2018.
88. Lee JH. Taxane-based or Platinum-based combination chemotherapy given concurrently with radiation followed by surgery resulting in high cure rates in esophageal cancer patients. ASCO 2018, 2018.
89. DaVee T, Deep A, Khuwaja S, Nogueras-Gonzalez GM, Thirumurthi S, Hurana A, Lum PJ, Shafi MZ, Blechacz B, Lee JH. The effect of prophylactic antibiotic timing on peristomal cellulitis following percutaneous endoscopic gastrostomy tube placement. DDW 2017, 2017.
90. DaVee T, Deep A, Khuwaja S, Thirumurthi S, Nogueras-Gonzalez GM, Lum PJ, Bhutani MS, Miller E, Lee JH. Does prior abdominal surgery increase the incidence of adverse events following percutaneous endoscopic gastrostomy tube placement. DDW 2017, 2017.
91. DaVee T, Deep A, Khuwaja S, Thirumurthi S, Nogueras-Gonzalez GM, Lum PJ, Raju GS, Lynch PM, Lee JH. Obesity does not affect adverse event risk following percutaneous endoscopic gastrostomy tube placement. DDW 2017, 2017.
92. DaVee T, Deep A, Khuwaja S, Thirumurthi S, Nogueras-Gonzalez GM, Lanke G, Lum PJ, Ross WA, Weston BR, Lee JH. Does poor abdominal wall transillumniation predict failed placement of percutaneous endoscopic gastrostomy tubes?. DDW 2017, 2017.
93. DaVee T, Deep A, Khuwaja S, Lanke G, Nogueras-Gonzalez GM, Raju GS, Lee JH. A pragmatic evaluation of targets set by the American Society for Gastrointestinal Endoscopy for ERCP priority quality indicators in a cancer population. DDW 2017, 2017.
94. DaVee T, Khuwaja S, Deep A, Lanke G, Nogueras-Gonzalez GM, Ross WA, Lee JH. Are prophylactic necessary to reduce the risk of post ERCP related infections in cancer patients?. DDW 2017, 2017.
95. DaVee T, Kukreja K, Glover M, Nogueras-Gonzalez GM, Raju GS, Ross WA, Weston BR, Lee JH. Does sphincterotomy reduce post-ERCP pancreatitis risk after covered metal biliary stent placement for malignant biliary obstruction?. DDW 2017, 2017.
96. DaVee T, Lanke G, Kukreja K, Arora A, Nogueras-Gonzalez GM, Lum PJ, Bhutani MS, Weston B, Lee JH. Does the accuracy of regional lymph node staging vary between esophageal squamous cell carcinoma and esophageal adenocarcinoma?. DDW 2017, 2017.
97. DaVee T, Glover M, Kukreja K, Nogueras-Gonzalez GM, Weston BR, Ross WA, Raju GS, Lee JH. Does chemoradiation prevent recurrent biliary obstruction following metal biliary stent placement?. DDW 2017, 2017.
98. DaVee T, Kukreja K, Glover M, Lanke G, Nogueras-Gonzalez GM, Lum PJ, Ross WA, Lee JH. Does chemoradiation increase ascending cholangitis risk after metal biliary stent placement for malignant biliary obstruction?. DDW 2017, 2017.
99. DaVee T, Kukreja K, Glover M, Lanke G, Nogueras-Gonzalez GM, Raju GS, Ross WA, Weston BR, Lee JH. Post ERCP cholecystitis after metal biliary stent placement: Do proximal malignant biliary strictures increase the risk?. DDW 2017, 2017.
100. DaVee T, Kukreja K, Glover M, Lanke G, Nogueras-Gonzalez GM, Lum PJ, Ross WA, Lee JH. Delayed pancreatitis risk with chemoradiation after metal biliary stent placement for malignant biliary obstruction. DDW 2017, 2017.
101. DaVee T, Lanke G, Kukreja K, Nogueras-Gonzalez GM, Lum PJ, Bhutani MS, Ross WA, Lee JH. Does histologic grade of esophageal cancer impact the accuracy of diagnostic staging modalities. DDW 2017, 2017.
102. DaVee T, Qazilbash M, Nogueras-Gonzalez GM, Lum PJ, Lanke G, Kukreja K, Shafi MA, Bhutani MS, Lee JH. Is endoscopic ultrasound more accurate than computed tomography in esophageal cancer staging?. DDW 2017, 2017.
103. DaVee T, Qazilbash M, Lanke G, Arora A, Nogueras-Gonzalez GM, Lum PJ, Shafi MA, Weston B, Ajani JA, Lee JH. Esophageal cancer regional lymph node staging: Endoscopic ultrasound versus positron emission tomography; which is better?. DDW 2017, 2017.
104. DaVee T, Deep A, Khuwaja S, Khurana A, Nogueras-Gonzalez GM, Lum PJ, Weston BR, Lee JH. Malignant intrahepatic biliary obstructions: do antibiotics prevent cholangitis in patients with incomplete biliary drainage?. DDW 2017, 2017.
105. DaVee T, Lanke G, Kukreja K, Nogueras-Gonzalez GM, Lum PJ, Bhutani MS, Ross WA, Ajani JA, Lee JH. Echosonographic characteristics of regional lymph nodes are predictive of malignant spread in esophageal cancer. DDW 2017, 2017.
106. Kaya DM, Wang X, Harada K, Blum-Murphy MA, Das P, Minsky B, Estrella JS, Lin Q, Amlashi FG, Lee JH, Weston B, Bhutani MS, Matamoros Jr. A, Sagebiel T, Wu CC, Hofstetter W, Badgwell BD, Ajani AJ. Long-term survival in 101 metastatic gastroesophageal cancer (mGEAC) patients eventually treated consolidative local therapy. ASCO 2016, 2016.
107. Papafragkakis C, Thaiudom S, Lanke Gandhi, Chakinala RC, Qiao W, Jaganmohan S, Lee JH. Clear Bile (CB) and Dark Bile (DB) in Malignant Biliary Obstruction with Naive Papilla: Does It Affect Survival?. DDW 2016, 2016.
108. Papafragkakis C, Thaiudom S, Lanke G, Chakinala RC, Wang X, Bhutani MS, Lee JH. Pancreatic Cancer Screening (PSC in High Risk Individuals (HRI) with Genetic Mutations. DDW 2016, 2016.
109. Papafragkakis C, Thaiudom S, Lanke G, Chakinala RC, Qiao W, Ross William, Weston BR, Davila ML, Raju GS, Lee JH. Outcomes of Stent-in-Stent (SIS) in the Management of Malignant Distal Biliary Obstruction (MDBO). DDW 2016, 2016.
110. Raju GS, Lum P, Ross W, Lynch PM, Thirumurthi S, Miller E, Blechacz B, Weston BR, Shafi M, Bhutani MS, Lee J, Davila ML, Stroehlein JR. Better management of patients with large colon polyps requires improvement in the knowledge gaps among referring endoscopists. ASGE 2016, 2016.
111. Raju GS, Lum P, Ross W, Lynch PM, Miller E, Thirumurthi S, Blechacz B, Lee JH, Shafi MA, Bhutani MS, Asif R, Weston BR, Davla ML, Stroehlein JR. Outcome of a protocol driven endoscopic resection of patients with large colon polyps (>20mm) results in low complications and recurrence. ASGE 2016, 2016.
112. Lee JH, Chan C, Lynch PM, Ross WA, Thirumurthi S, Bhutani MS, Weston B, Raju GS and Cassani LS. Safety and Effectiveness of Cap-assisted Endoscopic Mucosal Resection (EMR-C) and Conventional Endoscopic Mucosal Resection (EMR) for Large Nonampullary Duodenal Polyps (NADA) in Patients with Familial Adenomatous Polyposis (FAP) or Sporadic Duodenal Adenoma (SDA). ACG 2015, 2015.
113. Kirtane T, Cassani L, Davis DW, Lee JH. Endoscopy Video Forum: Endoscopic Ultrasound Features of Pancreatic Cystic Neoplasms. ACG 2015, 2015.
114. Lee TJ, Raju GS, Lee JH. Cap-assisted Endoscopic Mucosal Resection of A Large Non-ampullary Duodenal Adenoma. ACG 2015, 2015.
115. Slack RS, Ross WA, Lum P, Thirumurthi S, Weston B, Miller E, Lee JH, Shafi M, Davila M, Bresalier RS, Lynch PM, Shuttlesworth G, Mishra L, Stroehlein JR, Raju G. Reporting Adenoma Detection Rate Confidence Intervals Provide Better Feedback about Endoscopists' Performance. DDW 2015, 2015.
116. Shin EJ, Goggins MG, Chulick RD, Petersen GM, Hruban RH, Cosby H, Topazian M, Syngal S, Farrell JJ, Lee J, Khashab M, Lennon AM, Yeo CJ, Canto MI. Quality of Life and Cancer Worry of Individuals with Increased Risk for Familial Pancreatic Cancer. UEG Week 2015, 2015.
117. Gavini, Hemanth, Salvador DL, Chan C, Singh C, Ross W, Bhutani M, Weston BR, Lee JH. Comparison of imaging characteristics of CT, MRI, PET and EUS in the evaluation of metastasis to the pancreas: Results from a single tertiary cancer center. ACG, 2014.
118. Gavini H, Chouhan JS, Xiao L, Kwak N, Ross W, Bhutani M, Weston BR, Lee JH. The diagnostic yield of imaging modalities in screening for pancreatic cancer in symptomatic high risk individuals: Experience from a tertiary cancer center. ACG 2014, 2014.
119. Gavini H, Ahmad M, Singh C, Ross W, Bhutani M, Weston BR, Lee JH. Imaging characteristics, role of EUS-FNA and prognosis in patients with pancreatic lymphoma. ACG 2014, 2014.
120. Gavini H, Chouhan JS, Xiao L, Ross W, Weston BR, Raj G, Davila M, Javle M, Lee JH. The efficacy of ERCP and PTBD and comparison of survival in unilateral versus bilateral drainage in patients cholangiocarcinoma: Experience from a single tertiary cancer specialty institute. ACG 2014, 2014.
121. Gavini H, Chan C, Salvador D, Singh C, Ross W, Bhutani M, Weston BR, Lee JH. Evaluating the role of EUS-FNA in the diagnosis of metastasis to the pancreas: Results from a tertiary cancer center. ACG 2014, 2014.
122. Atiq M, Lee JH, Ross WA, Bhutani MS. Is it safe to follow cystic pancreatic neoplasms if immediate surgery is not undertaken?. DDW 2014, 2014.
123. Raju GS, Ross WA, Lum P, Lynch PM, Slack R, Miller E, Weston B, Davila ML, Thirumurthi S, Bhutani MS, Shafi M, Bresalier RS, Dekovich AA, Lee JH, Guha S, Blechacz B, Rashid A, Routbort M, Shuttlesworth G, Mishra L, Stroehlein JR. Natural Language Processing (NLP) as an alternative to manual reporting of colonoscopy quality metrics. DDW 2014, 2014.
124. Krishna SG, Bhattacharya, A, Ladha HS, Porter K, Ross WA, Bhutani MS, Weston BR, Katz MH, Fleming JB, Lee JH. Diagnosis of pancreatic adenocarcinoma: A review of 723 patients with solid pancreatic neoplasms at a single center. DDW 2014, 2014.
125. Kutlu O, Rueth NM, Vauthey JN, Katz MH, Lee JH, Fleming JB, Aloia TT, Lee JE, You YN, Lynch PM, Conrad C. Minimally Invasive Duodenoampullectomy in patients with familial adenomatous polyposis. DDW 2014, 2014.
126. Gavini H, Sheu-Woc W, Lee JH. Outcomes of Unilateral vs Bilateral drainage in Cholangiocarcinoma-Report from a Cancer Specialty Institute (CSI). DDW 2014, 2014.
127. Gavini H, Sheu-Woc W, Singh A, Ross WA, Ajani JA, Bhutani MS, Weston BR, Hofstetter WL, Davila ML, Raju Gottumukkala S, Welsh JW, Lee JH. Is a repeat endoscopy (EGD) necessary when referred for staging of newly diagnosed esophageal cancer?. DDW 2014, 2014.
128. Gavini H, Sheu-Woc W, Arukala V, Lynch PM, Mishra L, Fleming JB, Thirumurthi S, Ross WA, Conrad C, Weston BR, Lee JH. Difference in characteristics and tumor biology of ampullary adenomas in patients with FAP and sporadic adenomas. DDW 2014, 2014.
129. Shiozaki H, Sudo K, Wadhwa R, Hofstetter WL, Skinner HD, Komaki R, Lee JH, Weston B, Bhutani MS, Maru DM, Blum MA, Ajani JA. Distribution and timing of distant metastasis (DM) after definitive therapy for patients with esophageal and esophagogastric junction (E-EGJ) cancer. ASCO 2014, 2014.
130. Sudo K, Wang X, Wadhwa R, Shiozaki, Hofstetter WL, Rice DC, Lee JH, Bhutani MS, Weston B, Skinner HD, Komaki R, Maru DM, Blum MA, Ajani JA. Clinical parameters' model for predicting distant metastasis (DM) following definitive therapy in patients with localized esophageal and esophagogastric junction (E-EGJ) cancer. ASCO 2014, 2014.
131. Wadhwa R, Wang X, Izzo J, Skinner HD, Lee JH, Bhutani MS, Weston B, Ross WA, Hofstetter WL, Maru DM, Rice DC, Sudo K, Shiozaki H, Blum MA, Chen Q, Jin J, Song S, Baladandayuthapani B, Ajani JA. Pre-treatment nuclear Gli-1 labeling indices (lIs) correlate with initial SUV (iSUV) in esophageal cancer (EC) patients undergoing trimodality therapy (TMT). A potential pathway to esophageal preservation. ASCO 2014, 2014.
132. Krishna SG, Bhattacharya A, Ladha HS, Singh A, Ross WA, Bhutani MS, Fleming JB, Lee JH. Pretest probability and diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for pancreatic adenocarcinoma at a tertiary care oncology center: A 12 year experience. Digestive Disease Week 2013, 2013.
133. Krishna SG, Bhattacharya A, Ladha HS, Singh A, Ross WA, Bhutani MS, Fleming JB, Lee JH. Pretest evaluation of solid pancreatic lesions (SPLs) and utility of EUS-guided fine needle aspiration (EUS-FNA) for diagnostic differentiation between malignant tumors. Digestive Disease Week 2013, 2013.
134. Krishna SG, Bhattacharya A, Ladha HS, Singh A, Ross WA, Bhutani MS, Fleming JB, Lee JG. Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for diagnosis of cystic pancreatic lesions (CPL): Comprehensive evaluation, multidisciplinary dialogue and continued challenges at a tertiary oncology center. Digestive Disease Week 2013, 2013.
135. Singh A, Ross WA, Krishna SG, Bhattacharya A, Ladha HS, Noueras Gonzalez GM, Varadhachary GR, Fleming JB, Raju GS, Lee JH. Management of Self-Expanding Metal Stent Occlusion in Patients with Malignant Biliary Obstruction. Digestive Disease Week 2013, 2013.
136. Singh, Ladha HS, Bhattacharya A, Welsh JW, Qiao W, Krishna SG, Ross WA, Bhutani MS, Ajani JA, Hofstetter WL, Swisher S, Lee JH. Is Dilation Necessary to Complete EUS staging for esophageal cancer?. Digestive Disease Week 2013, 2013.
137. Singh A, Bhattacharya A, Xiao L, Ross WA, Dekovich AA, Lee JE, Lynch PM, Davila ML, Krishna SG, Lee JH. Comparison of Gastrojejunostomy and Enteral SEMS in Management of Malignant Gastric Outlet Obstruction-A Single Tertiary Care Cancer Center Experience. Digestive Disease Week 2013, 2013.
138. Singh A, Hofstetter WL, Bhattacharya A, Ladha HS, Qiao W, Ross WA, Bhutani MS, Krishna SG, Ajani JA, Maru D, Lee JH. Accuracy of Endoscopic Ultrasound in Differentiation of Mucosal and Submucosal Esophageal Cancer at a Tertiary Cancer Care Center. Digestive Disease Week 2013, 2013.
139. Singh A, Bhattacharya A, Ladha HS, Krishna SG, Ross WA, Bhutani MS, Ajani JA, Hofstetter WL, Lee JH. Is Second Look for Staging of Newly Diagnosed Esophageal Cancer Necessary?. DDW 2013, 2013.
140. Singh A, Bhattacharya A, Ladha HS, Kwak N, Krishna SG, Ross WA, Bhutani MS, Ajani JA, Erasmus J, Hofstetter WL, Swisher S, Lee JH. Comparison of Lymph Node Detection on PET and EUS in Patients with Esophageal Cancer. Digestive Disease Week 2013, 2013.
141. Singh A, Kwak NH, Ladha HS, Bhattacharya A, Krishna SG, Ross WA, Bhutani MS, Tamm EP, Bhosale P, Raju GS, Fleming JB, Lee JH. Yield of Endoscopic Ultrasound in Screening for Pancreatic Cancer at a Tertiary Cancer Center. Digestive Disease Week 2013, 2013.
142. Suzuki A, Xiao L, Taketa T, Sudo K, Blum MA, Komaki R, Liao ZX, Lee JH, Bhutani MS, Weston B, Hofstetter WL, Swisher S, Ajani JA. Various clinical outcomes n patients with esophageal or gastroesophageal junction (E-GEJ) adenocarcinoma undergoing trimodality therapy: Prognostic implications. ASCO 2013 Gastrointestinal Cancers Symposium, 2013.
143. Campagna MC, Taketa T, Correa AM, Suo K, Blum MA, Wadhwa R, Komak R, Lee JH, Bhutani MS, Weston B, Liao ZX, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Association of Relapse in patients with esophageal and esophagogastric junction (E-GEJ) cancer is highly associated with surgical stage after trimodality therapy (TMT): Implications for customized surveillance. ASCO 2013 Gastrointestinal Cancers Symposium, 2013.
144. Wadhwa R, Taketa T, Correa AM, Sudo K, Blum MA, Campagna MC, Komaki R, Lee JH, Bhutani M, Weston B, Liao Z, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Incidence of brain metastases following trimodality therapy (TMT) in patients with esophageal and gastroesophageal (E-EGCJ) cancer. ASCO 2013 Gastrointestinal Cancers Symposium, 2013.
145. Lee JH. Trimodality therapy (TMT) for patients with esophageal and esophagogastric junction (E-EGJ) cancer is associated with low rate of local-regional relapse and rare luminal-only relapse: implications for the surveillance strategy. ASCO 2013-Gastrointestinal Cancers Symposium, 2013.
146. Taketa T, Xiao L, Suzuki A, Blum MA, Sudo K, Lee JH, Weston B, Bhutani MS, Lin SH, Wadhwa R, Swisher S, Hofstetter WL, Ajani JA. 16-covariate propensity score matching between trimodality (TMT)-eligible esophagogastric cancer (EC) patients who had surgery and those who declined surgery after preoperative chemoradiation. ASCO 2013-Gastrointestinal Cancers Symposium, 2013.
147. Sudo K, Taketa T, Correa AM, Campagna MC, Wadhwa R, Blum MA, Komaki R, Lee JH, Bhutani MS, Weston B, Liao ZX, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Association of trimodality therapy (TMT) with rate of local-regional relapse and rare luminal-only relapse for patients with esophageal and esophagogastric junction (E-EGJ) cancer: Implications for the surveillance strategy. ASCO 2013 Gastrointestinal Cancer Symposium, 2013.
148. Shin EJ, Goggins MG, Schulick RD, Petersen GM, Hruban RH, Cosby H, Topazian M, Syngal S, Farrell JJ, Lee JH, Khashab M, Lennon AM, Yeo CJ, Canto MI. Quality of life and cancer worry of individuals with increased risk for familial pancreatic cancer. CAPS conference, 2013.
149. Hayashi Y, Xiao L, Suzuki A, Blum MA, Sabloff B, Taketa T, Maru DM, Welsh J, Lin SH, Weston B, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Ajani JA. A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with esophageal cancer (EC). ASCO 2012 Annual Meeting, 2012.
150. Wang W, Shpaner A, Krishna S, Ross WA, Bhutani MS, Tamm EP, Raju GS, Xiao L, Lee JH. Utilization of EUS-FNA in diagnosing pancreatic neoplasms without definitive masses on CT scans. DDW 2012, 2012.
151. Shin E, Topazian M, Syngal S, Farrell J, Goggins M, Saltzman JR, Lee JH. Radial Versus Linear and Second Look Endoscopic Ultrasound (EUS) Improved Detection of Pancreatic Lesions: A Randomized Tandem Study. DDW 2012, 2012.
152. Vadyala V, Krishna SG, Walker L, Mahometano L, Davila ML, Lee JH, Ross WA, Bhutani MS, Guha S, Stroehlein JR, Lynch PM, Raju GS. Clip closure after endoscopic mucosal resection (EMR) of > 20 mm lateral spreading tumors of the colon allows discharge of patients immediately after the procedure. ASGE DDW 2012, 2012.
153. Krishna SG, Fleming JB, Ross WA, Bhutani MS, Foo WC, Gong Y, Raju GS, Lee JH. Non-ampullary duodenal carcinoids: Role of endosonography and outcome of endoscopic mucosal resection. DDW 2012, 2012.
154. Krishna SG, Dang S, Ross WA, Foo WC, Lee JH. Pancreatic involvement in multiple myeloma: clinical and diagnostic features for the gastroenterologist. DDW 2012, 2012.
155. Krishna SG, Ross WA, Fleming JB, Bhutani MS, Foo WC, Raju GS, Weston BR, Dang SM, Lee JH. Large duodenal adenomas (> 1cm): is EUS necessary before endoscopic mucosal resection (EMR)?. DDW 2012, 2012.
156. Suzuki A, Xiao L, Hayashi Y, Blum MA, Welsh JW, Lin SH, Lee JH, Bhutani MS, Maru DM, Hofstetter WL, Erasmus J, Ajani JA. Nomograms for Prognostication of Patients with Esophageal and Gastroesophageal Carcinoma Undergoing Definitive Chemoradiotherapy. ASCO 2012, 2012.
157. Lin SH, Myles B, Wang L, Thall PF, Vaporciyan AA, Mehran RJ, Swisher SG, Lee JH, Bhutani MS, Mar DM, Ajani JA, Cox JD, Komaki R, Liao Zhongxing. Propensity matched analysis to compare outcomes of 3D conformal radiotherapy (3D-CRT) to Intensity Modulated Radiation Therapy (IMRT) in the treatment of esophageal cancer. ASCO, 2012.
158. Lee JH. Prognostic significance of post-treatment standardized uptake value (pSUV) of positron emission tomography (PET) to predict overall survival (OS) and relapse free survival (RFS) in patients with esophageal or gastroesophageal cancer treated with definitive chemoradiotherapy. ASCO Annual Meeting 2011, 2011.
159. Ajani JA, Correa A, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Suzuki A, Lee JH, Bhutani M, Lin SH, Welsh J, Maru DM, Swisher SG. The association between body mass index and baseline clinical stage of esophageal carcinoma. ASCO Annual Meeting 2011, 2011.
160. Suzuki A, Lianchun X, Hayashi Y, Welsh J, Lin SH, Lee JH, Bhutani M, Hofstetter W, Mehran RJ, Ajani JA. Value of the primary tumor initial standardized uptake value (iSUV) of 18F-fluorodeoxyglucose positron emission tomography (PET) to predict overall survival (OS) in patients with esophageal or gastroesophageal junction carcinoma undergoing definitive chemoradiotherapy. ASCO GI Symposium 2011, 2011.
161. Ajani JA, Wang X, Hayashi Y, Maru D, Welsh J, Hofstetter WL, Lee JH, Bhutani M, Berry D, Izzo J. Validated Biomarker Signatures that Predict Pathologic Response to Preoperative Chemoradiation Therapy (CTRT) with High Specificity and Desirable Sensitivity Levels in Patients with Esophageal Cancer (EC), 2011.
162. Singh A, Ross WA, Atiq M, Davila M, Raju GS, Bhutani MS, Lee JE, Fleming JB, Weston BR, Lee JH. Outcomes of Duodenal Stent vs. Gastrojejunostomy in Patient with Malignant Gastric Outlet Obstruction - report from tertiary cancer center. ACG 2011, 2011.
163. Kim HN, Lee JH, Ross WA. Role of ERCP in evaluation of post-stem cell transplantation patients with hepatobiliary disease. ACG Annual Meeting/poster, 2010.
164. Lee, JH. Endoscopic treatment for biliary leaks and strictures. Society of Gastrointestinal Intervention, 2010.
165. Atiq M, Kulkarni P, Ross WA, Bhutani M, Lee JH. Diagnostic Utility of EUS-FNA for suspected pancreatic malignancy excluding obvious cystic lesions on CT imaging, MD Anderson Cancer Center experience. Society of Gastrointestinal Intervention, 2010.
166. Singal A, Ross WA, Varadhachary GR, Javle M, Jaganmohan SR, Raju RP, Fleming J, Raju GS, Lee JH. Metal stents in surgically resectable pancreatic cancer: Single center experience on eighty three cases. ASGE/DDW 2010 poster, 2010.
167. Raju RP, Jaganmohan S, Ross WA, Stroehlein JR, Raju G, Wallace MJ, Javle M, Lee JH. Optimal Palliation of inoperable hilar cholangiocarcinoma: Comparative assessment of the efficacy of plastic and self-expandable metal stents. DDW 2010/poster, 2010.
168. Jaganmohan S, Raju RP, Ross WA, Javle M, Varadhachary GR, Raju GS, Abbruzzese J, Fleming JB, Stroehlein JR, Lee JH. Clear bile on ERCP for malignant biliary obstruction - incidental finding or an ominous sign? A comparative study. DDW 2010/ poster, 2010.
169. Raju RP, Jaganmohan S, Bektas M, Bhutani MS, Lee JH. Prognostic implications of high-grade malignant esophageal strictures in esophageal cancer. DDW 2010/poster, 2010.
170. Lee JH, Dasari CS, Harvinder S, Rashid A, Bhutani M, Raju RP, Jaganmohan S, Yao J, Phan Alexandria, Raju GS. Neuroendocrine tumors of the gastrointestinal tract and pancreas: diagnostic modalities, accuracy, and outcomes. DDW 2010/poster, 2010.
171. Jaganmohan S, Raju RP, Bhutani MS, Raju GS, Stroehlein JR, Lee JH. Risk of pancreatic cancer development in cancer survivors in the United States-a population-based epidemiological study using the seer database. DDW 2010/poster, 2010.
172. Canto MI, Schulick RD, Kamel IR, Fishman EK, Topazian MD, Takahashi N, Lee JH, Tamm EP, Vikram R, Syngal S, Saltzman JR, Mortele, KJ, Farrel JJ, Margolis D, Zhang Z, Petersen GM, Huban RH, Goggins MG. Screening for Familial Pancreatic Neoplasia: A Prospective, Multicenter Blinded Study of EUS, CT and Secretin-MRCP. Gastrointest Endosc 71(5):AB119, 2010.
173. Kim MP, Hofstetter WL, Correa A, Marom EM, Maru DM, Macapinlac H, Lee JH, Rice DC, Roth JA, Walsh GL, Mehran RJ, Vaporciyan AA, Swisher SG. Pathologic T0N1 after neoadjuvant Therapy and Surgery for Esophageal Cancer: an Orphan Status. Society of Thoracic Surgeons 46th Annual Meeting:174-175, 2010.
174. Wolf DS, Ross WA, Ajani JA, Hofstetter WL, Swisher SG, Rice D, Anandasabapathy S, Erasmus J, Lee JH. Diagnostic Accuracy of Endoscopic Ultrasound (EUS) and Management of T1 (T1 and T1b) Esophageal Cancer (EC). DDW, 2009.
175. Hofstetter W, Correa A, Lee J, Shah N, Komaki R, Erasmus J, Maru D, Lee JH, Walsh G, Vaporciyan A, Rice D, Mehran R, Roth J, Ajani J and Swisher S. Salvage resection for esophageal adenocarcinoma after failed definitive chemoradiation. ASCO GI Meeting, Poster, 2009.
176. Swisher SG, Hofstetter W, Komaki R, Correa AM, Erasmus J, Liao Z, Lee JH, Maru D, Mehran R, Patel S, Phan A, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Ajani JA. Sequential Phase II/III Trials with Preoperative Chemo or Chemoradiotherapy Strategies in Locoregionally Advanced Esophageal Cancer. American Surgical Association, 2009.
177. Gaur P, Sepesi BA, Bhutani MS, Hofstetter W, Correa AM, Ajani JA, Erasmus J, Komaki R, Lee JH, Maru D, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Watson TJ, and Swisher SG. Endoscopic Esophageal Tumor Length (cL) Identifies Esophageal Cancer Patients with High Risk of Lymph Node Involvement and Poor Long-Term Survival: Internal and External Validation. American Surgical Association, 2009.
178. Swisher SG, Hofstetter W, Komaki R, Correa AM, Erasmus J, Liao Z, Lee JH, Maru D, Mehran R, Patel S, Phan A, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, and Ajani JA. Long-term Outcome of Sequential Phase II/III Trials with 5-FU Based Preoperative Chemo or Chemoradiotherapy Strategies in Locoregionally Advanced Esophageal Cancer. ASCO, 2009.
179. Fan X, Lee JH, Sellin JH, Guha S. Prevalence of Barrett's esophagus in patients with esophageal adenocarcinoma and its association with cancer location and surveillance program. AGA/DDW poster, 2009.
180. Shpaner A, Ross WA, Varadhachary G, Javle M, Evans DB, Fleming JB, Tamm EP, Lee JH. Endoscopic ultrasound (EUS) detection of pancreatic neoplasms in patients without definitive pancreatic mass on computed tomography (CT) scan. ASGE/DDW poster, 2009.
181. Egwim CE, Wallace MJ, Wong M, Lee JH, Madoff DC, Ross WA. Outcomes in Lymphoma Patients with obstructive Jaundice. DDW 2009 Gastrointest Endosc, 2009.
182. Jaganmohan S, Varia A, Lee JH. Management of Duodenal lesions in Familial Adenomatous Polyposis (FAP). DDW/ASGE 2009 poster, 2009.
183. Lee JH, Dasari CS, Bhutani MS, Ross WA, Bektas M, Raju GS. Neuroendocrine Tumors of Gastrointestinal Tract and the Pancreas: Diagnostic Accuracy and Outcomes. ACG, 2009.
184. Thatte R, Guha S, Lee JH, Ross WA. Epidemiology and endoscopic management of large colon polyps: Preliminary analysis of a cancer center experience. ACG, 2009.
185. Fan X, Lee JH. EUS evaluation of HGD of esophagus is beneficial for patients with focal nodule or nodular mucosa. ACG, 2009.
186. Bektas M, Ross WA, Lee JH, Bhutani MS. EUS FNA for diagnosis of cystic pancreatic neuroendocrine tumors: An important cause for pancreatic cysts. ACG, 2009.
187. Bektas M, Lee JH, Guha S, Ross WA, Bhutani MS. Prevalence of extrapancreatic cysts in patients with cystic neoplasms of the pancreas. ACG, 2009.
188. Leung, KK, Ross W, Lin E, Lee JH. Diagnosis, antibiotic prophylaxis, and natural history of pancreatic cystic neoplasms: Is immediate surgery necessary?. ACG 2008, 2008.
189. Weston BR, Iyer RB, Lee JH, Ross WA. Clinical Significance of Incidental 18F-FDG Uptake in the Colon on PET/CT: Colonoscopic findings in a case control study. DDW/ASGE 2008, 2008.
190. Rice DC, Lee JH, Jimenez C, Eapen G, Stewart J, Hofstetter WL, Mehran R, Vaporciyan AA, Walsh GL, Swisher SG. Mediastinal Staging for Mesothelioma: Endoscopic Ultrasound or Mediastinoscopy?, 2008.
191. Settle, SH, Crane CH, Hodges JC, Das P, Varadhachary G, Tamm EP, Javle M, Lee JE, Fleming JB, Lee JH, Krishnan S, Evans DB, Wolff RA. Novel Use of Focal High-Dose IMRT for Borderline Resectable Pancreatic Cancer, 2007.
192. Nasroulah F, Varadhachary GR, Abbruzzese JL, Crane C, Tamm EP, Lee JE, Wang H, Lee JH, Evans DE, Wolff RA. Serum CA19-9 is a prognostic but not a predictive marker in patients (pts) with resected pancreatic cancer (PC) undergoing preoperative (preop) chemoradiation(CT-RT), 2007.
193. Piesman M, Baron T, Lee JH, Edmundowicz S, Miqdadi J, Carr-Locke DL. A Prospective, Multi-Center Patency Study of the Luminexx. DDW poster, 2007.
194. Goetz GH, Lee JH, Davila M, Fukami N, Ross WA. Performance of Covered vs Uncovered metal stents in malignant strictures of the common duct. DDW poster, 2007.
195. Leung KK, Thirumurthi S, Ross WA, Lin E, and Lee JH. The Prognostic Value of Endoscopic Ultrasound Parameters, Serum Tumor Markers, Cyst Fluid Tumor Markers and Cyst Fluid Viscosity in Pancreatic Cyst Neoplasms. DDW poster, 2007.
196. Lee JH. The Choice of Antibiotic Prophylaxis Prior to Endoscopic Ultrasound with Fine-Needle Aspiration of a Pancreatic Cyst. DDW poster, 2007.
197. Lee JH, Stewart J, Anandasabapathy S, Thirumurthi S, Ross WA, Lin E, and Staerkel G. Comparison of performance of 22-gauge and 25-gauge needles in Endoscopic Ultrasound Guided Fine-needle aspiration. DDW poster, 2007.
198. Weston BR, Ross WA and Lee JH. EUS-guided transesophageal FNA in the evaluation of non-esophageal cancer related mediastinal lesions. DDW poster, 2007.
199. Nasroulah F, Varadhachary GR, Abbruzzese JL, Crane C, Tamm EP, Lee JE, Wang H, Lee JH, Evans DE, Wolff RA. Serum CA 19-9 is a prognostic but not a predictive marker in patients (pts) with resected pancreatic cancer (PC) undergoing preoperative (preop) chemoradiation (CT-RT). GI ASCO, 2007.
200. Varadhachary GR, Wolff RA, Crane CH, Lee JE, Abdalla EK, Lee JH, Pisters PWT, Ho L, Abbruzzese JL, Evans DB. Preoperative gemcitabine (gem) and bevacizumab (bev) based chemoradiation for resectable pancreatic adenocarcinoma. GI ASCO, 2007.
201. Weston BR, Ross WA, Lin E, Wang X, Lee JH. What happens to serum carbohydrate antigen 19-9 after biliary stent placement in pancreaticobiliary malignancy?. ACG poster, 2006.
202. Lee JH. Endoscopic management of Barrett's with high-grade dysplasia and intramucosal cancer. ISGIO Conference podium presentation, 2006.
203. Lee JH. Management of Esophageal Cancer and Barrett's Esophagus. 3rd Annual Official Meeting, Int'l Society of GI Oncology (ISGIO)-Arlington, VA, 2006.
204. Goetz D, Lee JH, Fukami N, Davila ML, Ross WA. Complications following endoscopic stent placement for malignant biliary obstruction: preliminary analysis. DDW AGA poster, 2006.
205. Ross WA, Dekovich AA, Cleary KR, Ghosh S, Lee JH, Couriel DR. Endoscopic diagnosis of early gastrointestinal graft-versus-host disease. DDW AGA podium presentation, 2006.
206. Weston BR, Ross WA, Wang X, Xiao L, Wolff RA, Evans DB, Lee JH. Rate of bilirubin regression post biliary stent placement in malignant obstruction. DDW ASGE poster, 2006.
207. Frank C, Ross WA, Prindiville T, Lee JH. Accuracy of EUS and PET staging of gastrointestinal cancers. DDW ASGE poster, 2006.
208. Varadhachary G, Evans D, Crane CH, Xiong HQ, Lee JE, Pisters PW, Abdalla E, Tamm EP, Lee JH, Wolff RA. Interim results of preoperative gemcitabine (gem) plus cisplatin followed by rapid fractionation chemoradiation for resectable pancreatic adenocarcinoma. ASCO poster, 2006.
209. Izzo JG, Wu TT, Luthra R, Malhotra U, Luthra M, Milas L, Liao Z, Swisher S, Lee JH, Bresalier RS, Hittelman WN, Aggarwal BB, Ajani JA. Activated Transcription Factor NF-kB is Associated with Chemo-Radiotherapy Resistance and Poor Outcome in Esophageal Adenocarcinoma. ASCO, Orlando, FL May, 2005.
210. Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Liao Z, Phan A, Rice D, Vaporciyan AA, Walsh GL, Lahoti S, Lee JH, Bresalier R, Roth JA, Swisher SG . EUS-Identified Celiac Adenopathy Remains a Poor Prognostic Factor Despite Preoperative Chemoradiotherapy In Patients with Adenocarcinoma of the Distal Esophagus. Association of Thoracic Surgery, San Francisco, CA, Oral Presentation. April, 2005.
211. Mullen JT, Gomez HF, Lee JH, Ross WA, Abdalla EK, Vauthey J-N, Lee JE, Pisters PWT, Evans DB . Pancreaticoduodenectomy Following Placement of Expandable Metal Stents. DDW (SSAT) Plenary session, Chicago, IL May , 2005.
212. Wasan S, Lahoti S, Ross W, Staerkel G, Lee JH. EUS-guided FNA and ERCP in One Session in Presumed Malignant Biliary Obstruction. DDW Poster ASGE Section, May, 2005.
213. Kalha I, Wasan SM, Staerkel G, Lahoti S, Lee JH. Utility of Endoscopic Ultrasound and Fine Needle Aspiration In Diagnosing Uncommon Pancreatic Tumors. ACG Plenary Session 268:AB582, 2004.
214. Wasan SM, Evans D, Ross W, Lee JH. Metal Stents In Surgically Resectable Pancreatic Cancer. Oral Presentation, ACG Plenary Session 105:3, 2004.
215. Lee JH, Raina D, Aslanian H, Chacho M, Topazian M. Complications Of Endoscopic Ultrasound and Fine Needle Aspiration of Pancreatic Cysts. DDW ASGE, 2003.
216. Lee JH, Salem R, Aslanian H, Chacho M, Topazian M. Endoscopic Ultrasound and Fine Needle Aspiration. DDW ASGE, 2003.
217. Sheehan S, Lee JH, Wells CK, Topazian M. Serum Amylase, Pancreatic Stenting, and Pancreatitis after Sphincter of Oddi Manometry. ACG, Oct, 2003.
218. Aspelund G, Topazian MD, Lee JH, Andersen DK. Improved outcomes with limited pancreatic head resections for benign disease. SSAT, 2002.
219. Lee JH, Johannes R, Van Dam J, Farraye F, Carr-Locke DL. How Best To Diagnose IPMT (Intraductal Papillary Mucinous Tumors). ASGE DDW, San Diego, May , 2000.
220. Lee JH, Johannes R, Van Dam J, Taitelbaum G, Piper J, Carr-Locke DL. Argon Plasma Coagulation in Endoscopic Therapy. ASGE DDW, San Diego, May, 2000.
221. Somnay K, Van Dam J, Lee JH, Shields S, Ruymann F, Carr-Locke DL. An Endoscopic Approach to Ampullary Adenomas. DDW Poster, Orlando Florida, May, 1999.
222. Lee JH. A single center clinicopathological study of comparison of pancreatic acinar cell carcinoma and its mixed differentiations. USCAP 2022 Annual Meeting.

Book Chapters

1. Lee JH. Endoscopic Management of Large Duodenal Adenomas. In: Practical Gastroenterology, 30-38, 2017.
2. Bhosale P, Fleming J, Das P, Javle M, Lee JH. Cystic Pancreatic Lesions. In: Oncologic Imaging. Bermedica Production, Ltd: Columbia, MD, 1-19, 2012.
3. Tamm EP, Balachandran A, Bhosale PR, Katz MH, Fleming JB, Lee JH, Varadhachary GR. Imaging of Pancreatic Adenocarcinoma: Update on Staging/Resectability. In: Radiologic Clinics of North America. WB Saunders, 407-428, 2012.
4. Lee JH, Kelsey P. Choledochoscopy and Pancreatoscopy. In: Successful training in gastrointestinal endoscopy. Wiley-Blackwell: New York, 116-124, 2011.
5. Lee JH, Tamm EP. Pancreatic Carcinoma: Detection and Staging. In: EUS Pathology with Digital anatomy Correlation. People's Medical Publishing House: Shelton, CT, 149, 2010.
6. Javle M, Abernethy A, Busaidy NL, Lee JH. Dilemmas in upper gastrointestinal cancers, focus on symptom improvement. In: 2009 ASCO Educational Book, 2009.
7. Yendamuri S, Lee JH, Rice DC. Malignant: Metastatic. In: Esophageal Cancer Principles and Practice. demosmedical, 355-359, 2009.
8. Lee JH, Ross WA. Invasive/Interventional Gastroenterology. In: Medical Care of Cancer Patients. BC Decker, 2008.
9. Lee JH, Wolf J. Complications of IBD, 61. In: Osteopenia and Osteoporosis: Prevention and Treatment, Advanced Therapies in Inflammatory Bowel Disease, P289-292, 2000.

Letters to the Editor

1. Litton JK, Lee JH, Arun BK. BRCA2 associated pancreatic cancer and current screening guidelines. Cancer.
2. Atiq M, Lee JH. Pancreatic Endocrine Microadenomatosis in a patient with ocul-facio-cardio-dental syndrome (OFCD). Pancreas 41: 327-9, 2012.
3. Lee JH, Paterson J, Greisman H, Jacobsen D, Farraye F. Asymptomatic Ileal Carcinoid Detected During Colonoscopy. Am J Gastroenterol 95: 851-852, 2000.